<html>
  <head>
    <title>
      Optimizing antibody affinity and stability by the automated design of the
      variable light-heavy chain interfaces
    </title>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge" />
    <link href="../themes/stencila/styles.css" rel="stylesheet" />
    <script src="../themes/stencila/index.ts" type="text/javascript"></script>
    <script
      src="https://unpkg.com/@stencila/components@&lt;=1/dist/stencila-components/stencila-components.esm.js"
      type="module"
    ></script>
    <script
      src="https://unpkg.com/@stencila/components@&lt;=1/dist/stencila-components/stencila-components.js"
      type="text/javascript"
    ></script>
  </head>

  <body>
    <article itemtype="https://schema.org/Article" itemscope="true">
      <h1 itemprop="headline">
        Optimizing antibody affinity and stability by the automated design of
        the variable light-heavy chain interfaces
      </h1>
      <div>
        <ol class="authors">
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Shira Warszawski"
              ><span itemprop="givenName">Shira</span
              ><span itemprop="familyName">Warszawski</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Aliza Borenstein Katz"
              ><span itemprop="givenName">Aliza</span
              ><span itemprop="familyName">Borenstein Katz</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-2">2</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Rosalie Lipsh"
              ><span itemprop="givenName">Rosalie</span
              ><span itemprop="familyName">Lipsh</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Lev Khmelnitsky"
              ><span itemprop="givenName">Lev</span
              ><span itemprop="familyName">Khmelnitsky</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-2">2</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Gili Ben Nissan"
              ><span itemprop="givenName">Gili</span
              ><span itemprop="familyName">Ben Nissan</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Gabriel Javitt"
              ><span itemprop="givenName">Gabriel</span
              ><span itemprop="familyName">Javitt</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-2">2</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Orly Dym"
              ><span itemprop="givenName">Orly</span
              ><span itemprop="familyName">Dym</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-3">3</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Tamar Unger"
              ><span itemprop="givenName">Tamar</span
              ><span itemprop="familyName">Unger</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-3">3</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Orli Knop"
              ><span itemprop="givenName">Orli</span
              ><span itemprop="familyName">Knop</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Shira Albeck"
              ><span itemprop="givenName">Shira</span
              ><span itemprop="familyName">Albeck</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-3">3</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Ron Diskin"
              ><span itemprop="givenName">Ron</span
              ><span itemprop="familyName">Diskin</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-2">2</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Deborah Fass"
              ><span itemprop="givenName">Deborah</span
              ><span itemprop="familyName">Fass</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-2">2</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Michal Sharon"
              ><span itemprop="givenName">Michal</span
              ><span itemprop="familyName">Sharon</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
          <li
            itemtype="https://schema.org/Person"
            itemscope="true"
            itemprop="author"
          >
            <span itemprop="name" content="Sarel J. Fleishman"
              ><span itemprop="givenName">Sarel J.</span
              ><span itemprop="familyName">Fleishman</span></span
            >
            <ol class="affiliations">
              <li>
                <a itemprop="affiliation" href="#author-organization-1">1</a>
              </li>
            </ol>
          </li>
        </ol>
        <ol class="organizations">
          <li
            id="author-organization-1"
            itemtype="https://schema.org/Organization"
            itemscope="true"
            itemid="#author-organization-1"
          >
            <span itemprop="name"
              >Department of Biomolecular Sciences, Weizmann Institute of
              Science, Rehovot, Israel</span
            >
          </li>
          <li
            id="author-organization-2"
            itemtype="https://schema.org/Organization"
            itemscope="true"
            itemid="#author-organization-2"
          >
            <span itemprop="name"
              >Department of Structural Biology, Weizmann Institute of Science,
              Rehovot, Israel</span
            >
          </li>
          <li
            id="author-organization-3"
            itemtype="https://schema.org/Organization"
            itemscope="true"
            itemid="#author-organization-3"
          >
            <span itemprop="name"
              >Israel Structural Proteomics Center, Weizmann Institute of
              Science, Rehovot, Israel</span
            >
          </li>
        </ol>
      </div>
      <section>
        <h2>Abstract</h2>
        <div itemprop="description">
          <p>
            Antibodies developed for research and clinical applications may
            exhibit suboptimal stability, expressibility, or affinity. Existing
            optimization strategies focus on surface mutations, whereas natural
            affinity maturation also introduces mutations in the antibody core,
            simultaneously improving stability and affinity. To systematically
            map the mutational tolerance of an antibody variable fragment (Fv),
            we performed yeast display and applied deep mutational scanning to
            an anti-lysozyme antibody and found that many of the
            affinity-enhancing mutations clustered at the variable light-heavy
            chain interface, within the antibody core. Rosetta design combined
            enhancing mutations, yielding a variant with tenfold higher affinity
            and substantially improved stability. To make this approach broadly
            accessible, we developed AbLIFT, an automated web server that
            designs multipoint core mutations to improve contacts between
            specific Fv light and heavy chains (<a
              href="http://ablift.weizmann.ac.il/"
              >http://AbLIFT.weizmann.ac.il</a
            >). We applied AbLIFT to two unrelated antibodies targeting the
            human antigens VEGF and QSOX1. Strikingly, the designs improved
            stability, affinity, and expression yields. The results provide
            proof-of-principle for bypassing laborious cycles of antibody
            engineering through automated computational affinity and stability
            design.
          </p>
        </div>
      </section>
      <h1 id="introduction">Introduction</h1>
      <p>
        High-affinity natural antibodies are generated through an iterative
        process of mutation and selection for antigen binding known as affinity
        maturation. Affinity maturation also selects antibodies that exhibit
        higher stability and expressibility [<cite
          ><a href="#pcbi.1007207.ref001">#pcbi.1007207.ref001</a></cite
        >], both of which are essential parameters in the development of
        antibodies into research or medical tools [<cite
          ><a href="#pcbi.1007207.ref002">#pcbi.1007207.ref002</a></cite
        >]. In recent decades, synthetic antibody repertoires have been widely
        adopted in antibody discovery and optimization, providing greater
        control over the selection process than animal immunization. In this
        approach, a library of antibody variable fragments (Fv) is displayed,
        for instance on yeast cells, and screened to select high-affinity
        binders or to improve the affinity of existing antibodies [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >]. These methods are powerful [<cite
          ><a href="#pcbi.1007207.ref004">#pcbi.1007207.ref004</a></cite
        >,<cite><a href="#pcbi.1007207.ref005">#pcbi.1007207.ref005</a></cite
        >], but a large fraction of high-affinity antibodies isolated from
        synthetic repertoires exhibits impaired stability [<cite
          ><a href="#pcbi.1007207.ref006">#pcbi.1007207.ref006</a></cite
        >]. Impaired stability can limit expression yields and increase
        aggregation propensity [<cite
          ><a href="#pcbi.1007207.ref007">#pcbi.1007207.ref007</a></cite
        >], resulting in high production costs [<cite
          ><a href="#pcbi.1007207.ref008">#pcbi.1007207.ref008</a></cite
        >], fast antibody clearance from circulation and adverse immune
        responses in patients [<cite
          ><a href="#pcbi.1007207.ref009">#pcbi.1007207.ref009</a></cite
        >]. Thus, the tradeoff between antibody stability (including solubility
        and expressibility) and affinity can delay and even block the
        development of antibodies in research and medicine [<cite
          ><a href="#pcbi.1007207.ref010">#pcbi.1007207.ref010</a></cite
        >]. General methods to improve antibody stability while maintaining or
        even increasing affinity are therefore urgently needed to reduce the
        attrition rate in antibody development pipelines [<cite
          ><a href="#pcbi.1007207.ref011">#pcbi.1007207.ref011</a></cite
        >].
      </p>
      <p>
        To boost antibody stability and affinity, computational design methods
        have been developed. These have focused on the Fv
        complementarity-determining regions (CDRs), which are typically in
        direct contact with the antigen. Some methods, for instance, improved
        electrostatic complementarity with the antigen [<cite
          ><a href="#pcbi.1007207.ref012">#pcbi.1007207.ref012</a></cite
        >] or eliminated hydrophobic surface patches [<cite
          ><a href="#pcbi.1007207.ref013">#pcbi.1007207.ref013</a></cite
        >–<cite><a href="#pcbi.1007207.ref018">#pcbi.1007207.ref018</a></cite
        >]. Natural and laboratory affinity maturation, by contrast, introduce
        mutations in both the CDRs and the antibody core [<cite
          ><a href="#pcbi.1007207.ref001">#pcbi.1007207.ref001</a></cite
        >,<cite><a href="#pcbi.1007207.ref005">#pcbi.1007207.ref005</a></cite
        >]. Core mutations may improve antibody stability by eliminating packing
        defects, and they may enhance affinity by preorganizing the
        antigen-binding site [<cite
          ><a href="#pcbi.1007207.ref001">#pcbi.1007207.ref001</a></cite
        >]. Although mutations in the core may contribute less to affinity than
        ones in the CDRs, they are more likely to retain the intricate structure
        of the antigen-binding site and are therefore likely to be compatible
        with affinity-enhancing mutations in the CDRs that were obtained through
        other optimization strategies. The antibody core, however, is a large
        and densely packed region, complicating the design of improved variants
        [<cite><a href="#pcbi.1007207.ref005">#pcbi.1007207.ref005</a></cite
        >,<cite><a href="#pcbi.1007207.ref019">#pcbi.1007207.ref019</a></cite
        >]. For instance, we recently presented and validated an automated
        computational strategy, called PROSS [<cite
          ><a href="#pcbi.1007207.ref020">#pcbi.1007207.ref020</a></cite
        >], for protein-stability design. Similar to other stability design
        algorithms [<cite
          ><a href="#pcbi.1007207.ref021">#pcbi.1007207.ref021</a></cite
        >], however, PROSS only rarely introduces core mutations and does not
        improve binding affinity [<cite
          ><a href="#pcbi.1007207.ref022">#pcbi.1007207.ref022</a></cite
        >]. Reliable prediction of mutational effects in the antibody core and
        especially successful design of networks of interacting multipoint core
        mutations has, therefore, remained a challenge [<cite
          ><a href="#pcbi.1007207.ref021">#pcbi.1007207.ref021</a></cite
        >,<cite><a href="#pcbi.1007207.ref023">#pcbi.1007207.ref023</a></cite
        >].
      </p>
      <p>
        Recently, deep mutational scanning has been successfully applied to
        study the mutational tolerance of antibodies and other binders [<cite
          ><a href="#pcbi.1007207.ref024">#pcbi.1007207.ref024</a></cite
        >–<cite><a href="#pcbi.1007207.ref030">#pcbi.1007207.ref030</a></cite
        >]. In this approach, amino acid positions in the binder are
        systematically mutated to all of the natural amino acid identities; the
        mutants are pooled into one library containing all single-point
        mutations; populations of binders are selected from this library using
        <em>in vitro</em> display and high-throughput screening; and the
        selected and unselected populations are subjected to deep-sequencing
        analysis to infer which mutations are enriched relative to the starting
        binder, thus systematically identifying affinity-enhancing mutations.
        Deep mutational scanning has been very successfully used to guide
        protein design and engineering of improved binders [<cite
          ><a href="#pcbi.1007207.ref024">#pcbi.1007207.ref024</a></cite
        >,<cite><a href="#pcbi.1007207.ref026">#pcbi.1007207.ref026</a></cite
        >,<cite><a href="#pcbi.1007207.ref031">#pcbi.1007207.ref031</a></cite
        >,<cite><a href="#pcbi.1007207.ref032">#pcbi.1007207.ref032</a></cite
        >] but has not yet been exploited to improve protein-design methodology
        itself. The large improvements in the reliability and breadth of
        detection of affinity-enhancing mutations through deep mutational
        scanning inspired us to revisit the challenge of accurately predicting
        the effects of core mutations on antibody affinity and stability. Deep
        mutational scanning guided us in uncovering a cluster of core positions
        at the light-heavy chain (vL-vH) interface where many affinity-enhancing
        mutations occurred. We then used these systematic data to establish
        general rules for computational design of antibody Fvs with improved
        vL-vH interactions; we implemented these rules as an automated method,
        called AbLIFT and made it available through a web server (<a
          href="http://ablift.weizmann.ac.il/"
          >http://AbLIFT.weizmann.ac.il</a
        >). AbLIFT designs exhibited striking gains in affinity, stability, and
        expressibility in two unrelated antibodies that target the human disease
        markers Vascular-Epidermal Growth Factor (VEGF) and the enzyme Quiescin
        Sulfhydryl Oxidase 1 (QSOX1).
      </p>
      <h1 id="results">Results</h1>
      <h2 id="a-cluster-of-affinity-enhancing-mutations-at-the-vl-vh-interface">
        A cluster of affinity-enhancing mutations at the vL-vH interface
      </h2>
      <p>
        To study the mutational tolerance of an antibody Fv, we selected 135
        positions in the anti-lysozyme antibody D44.1 [<cite
          ><a href="#pcbi.1007207.ref033">#pcbi.1007207.ref033</a></cite
        >] for deep mutational scanning (<strong
          ><a href="#pcbi.1007207.s001">S1A Fig</a></strong
        >). The positions encompassed most of the CDRs, the vL-vH interface and
        additional peripheral positions (<strong
          ><a href="#pcbi.1007207.g001">Fig 1A</a></strong
        >). D44.1 and each point mutant were genetically encoded as single-chain
        variable fragments (scFv) in which the heavy chain was fused to the
        light chain via a flexible linker, and the genes were transformed into
        yeast cells for binding and expression screens by yeast display [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >]. Following incubation with hen egg-white lysozyme, the top 15%
        binders were selected from this library, and the same library was also
        subjected to low-stringency selection for expression levels to provide a
        baseline. The plasmids containing scFv-encoding genes from both
        selections were purified, amplified by PCR, and subjected to deep
        sequencing, resulting in 8 million high-quality reads [<cite
          ><a href="#pcbi.1007207.ref032">#pcbi.1007207.ref032</a></cite
        >]. We then determined the enrichment of each mutant relative to D44.1
        as the ratio between populations selected for binding and expression
        (<strong><a href="#pcbi.1007207.g001">Fig 1B</a></strong
        >).
      </p>
      <figure id="pcbi.1007207.g001" title="Fig 1">
        <img src="article-antibodies.html.media/g001.png" itemprop="image" />
        <figcaption>
          <h2 id="deep-mutational-scanning-of-an-antibody-variable-fragment-fv">
            Deep mutational scanning of an antibody variable fragment (Fv).
          </h2>
          <p>
            (<strong>a</strong>) 135 positions across the Fv of the
            anti-lysozyme antibody D44.1 (encompassing the vL-vH interface and
            all positions from the antigen-binding surface to the level of the
            disulfide-linked cysteines) were individually diversified using
            degenerate codons (NNS) to encode all point mutations. The variants
            were transformed into yeast cells, subjected to low-stringency
            selection for binding (green spots) and for expression (purple +
            green spots), and then to deep-sequencing analysis.
            (<strong>b</strong>) 34 Fv positions exhibited enhanced binding upon
            mutation (blue). Amino acids (x-axis) are numbered according to ref.
            [<cite><a href="#pcbi.1007207.ref033">#pcbi.1007207.ref033</a></cite
            >]. Blue, red and gray encode mutations that are enriched, depleted,
            or ones with insufficient data, respectively. Amino acid identities
            in the parental antibody are indicated in one-letter code for each
            position. (<strong>c</strong>) At several positions, more than five
            alternative identities enhanced affinity, indicating that the
            combinatorial sequence space of affinity-enhancing multipoint
            mutants is large. Positions at the vL-vH interface are colored
            purple. (<strong>d</strong>) Mutations were ranked according to
            their enrichment ratios, revealing that many (30%) of the top
            affinity-enhancing mutations occurred at the vL-vH interface (30
            identities at the eight positions with enrichment over the parental
            identity above threefold are marked in blue triangles).
            (<strong>e</strong>) Spheres indicate positions on the molecular
            structure of the bound HEL-D44.1 complex (PDB entry 1MLC) in which
            mutations exhibited at least threefold enrichment relative to D44.1.
            A cluster of enriched positions at the vL-vH interface, mostly
            belonging to the antibody framework, is highlighted in purple.
            HEL—hen egg-white lysozyme.
          </p>
        </figcaption>
      </figure>
      <p>
        We found affinity-enhancing mutations at 34 positions, mostly within the
        CDRs, as expected (<strong
          ><a href="#pcbi.1007207.g001">Fig 1C</a></strong
        >). We also noticed a surprisingly large cluster of eight positions at
        the vL-vH interface where affinity-enhancing mutations occurred,
        although they were not in direct contact with the antigen (<strong
          ><a href="#pcbi.1007207.g001">Fig 1D and 1E</a></strong
        >). This cluster of affinity-enhancing mutations in the vL-vH interface
        is intriguing for four reasons: (1) the vL-vH interface mediates the
        assembly of the Fv from the two antibody chains, and mutations in this
        region have the potential to also enhance stability through improved Fv
        assembly [<cite
          ><a href="#pcbi.1007207.ref001">#pcbi.1007207.ref001</a></cite
        >]; (2) the genetic pairing of light and heavy chains during germline
        antibody generation is a random process which may result in suboptimal
        vL-vH interfaces, flexibility in the antigen-binding site [<cite
          ><a href="#pcbi.1007207.ref034">#pcbi.1007207.ref034</a></cite
        >], and therefore in lower antigen affinity [<cite
          ><a href="#pcbi.1007207.ref035">#pcbi.1007207.ref035</a></cite
        >]; (3) this region is distant from the mutational hotspots in the CDRs
        and may not be fully optimized in the course of natural affinity
        maturation [<cite
          ><a href="#pcbi.1007207.ref036">#pcbi.1007207.ref036</a></cite
        >]; and (4) antibody-engineering procedures, such as humanization or CDR
        grafting may inadvertently compromise the structural integrity of this
        region by mispairing CDRs and frameworks [<cite
          ><a href="#pcbi.1007207.ref037">#pcbi.1007207.ref037</a></cite
        >]. Based on these considerations, we hypothesized that the vL-vH
        interface may be especially amenable to the design of multipoint mutants
        that simultaneously improve stability and affinity in both natural and
        engineered antibodies.
      </p>
      <p>
        Combining mutations in densely packed protein cores, such as the vL-vH
        interface, is challenging, however, because inadvertently introduced
        voids, steric overlaps, or mispaired polar amino acid side-chains can
        lead to protein instability, misfolding, and aggregation [<cite
          ><a href="#pcbi.1007207.ref021">#pcbi.1007207.ref021</a></cite
        >,<cite><a href="#pcbi.1007207.ref023">#pcbi.1007207.ref023</a></cite
        >]. We, therefore, asked whether the mutational-tolerance map could
        guide Rosetta design in finding improved multipoint mutants at the vL-vH
        interface. In preliminary calculations starting from the lysozyme-bound
        D44.1 structure (PDB entry: 1MLC), we restricted Rosetta combinatorial
        design to the eight positions and 38 identities (including the wild type
        identities) at these positions that showed at least threefold enrichment
        relative to D44.1 according to the mutational-tolerance map (<strong
          ><a href="#pcbi.1007207.g001">Fig 1B and 1E</a></strong
        >). The resulting design, however, comprised only three conservative
        mutations, suggesting that the dense packing and backbone rigidity at
        the vL-vH interface restricted sequence optimization. We, therefore,
        repeated design calculations but this time excluded the wild type
        identities at the eight positions, forcing the design of an optimal
        combination of mutations only from those that were substantially
        enriched in deep mutational scanning. We iterated sequence design and
        backbone and sidechain minimization to promote the acceptance of even
        radical mutations yielding design D44.1<sup>des</sup> with eight
        mutations. As a preliminary qualitative test, we analyzed D44.1<sup
          >des</sup
        >
        binding to lysozyme and to seven of the eight single-point mutations
        formatted as scFvs using yeast display [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >]. As expected, each of the point mutations improved the apparent
        binding affinity relative to D44.1; and yet, the multipoint D44.1<sup
          >des</sup
        >
        exhibited a substantial improvement in apparent affinity compared to the
        single-point mutations (<strong
          ><a href="#pcbi.1007207.s001">S1B Fig</a></strong
        >).
      </p>
      <p>
        To determine what molecular factors might underlie higher affinity in
        D44.1<sup>des</sup>, we expressed the design as an antigen-binding
        fragment (Fab) and determined its structure by X-ray crystallography in
        the absence of lysozyme (<strong
          ><a href="#pcbi.1007207.s007">S1 Table</a></strong
        >). Despite eight core mutations, the overall agreement between
        D44.1<sup>des</sup> and the bound structure of D44.1, which served as
        the starting point for designing D44.1<sup>des</sup>, was excellent
        (<strong><a href="#pcbi.1007207.s002">S2 Fig</a></strong
        >): The two structures deviated by &lt;1 Å backbone root-mean-square
        deviation (rmsd) and in side-chain residues comprising the
        lysozyme-binding site. The mutations apparently improved various
        molecular aspects of the vL-vH interface including interface packing,
        solvation, and backbone rigidity (<strong
          ><a href="#pcbi.1007207.g002">Fig 2A</a></strong
        >). Next, we tested lysozyme binding by D44.1 and D44.1<sup>des</sup>
        (both expressed and purified as Fab) using surface-plasmon resonance
        (SPR). D44.1<sup>des</sup> exhibited nearly tenfold improvement in
        affinity (<em>K</em><sub><em>D</em></sub> of 15 versus 135 nM for
        D44.1<sup>des</sup> and D44.1, respectively), with a 25-fold slower
        off-rate (8 * 10<sup>−4</sup> s<sup>-1</sup>) (<strong
          ><a href="#pcbi.1007207.g002">Fig 2B</a></strong
        >). D44.1<sup>des</sup> also exhibited improved thermal denaturation and
        aggregation resistance (<strong
          ><a href="#pcbi.1007207.g002">Fig 2C and 2D</a></strong
        >).
      </p>
      <figure id="pcbi.1007207.g002" title="Fig 2">
        <img src="article-antibodies.html.media/g002.png" itemprop="image" />
        <figcaption>
          <h2
            id="gains-in-affinity-stability-and-aggregation-resistance-through-vl-vh-interface-design-guided-by-deep-mutational-scanning"
          >
            Gains in affinity, stability, and aggregation resistance through
            vL-vH interface design guided by deep mutational scanning.
          </h2>
          <p>
            (<strong>a</strong>) Comparison of the starting anti-lysozyme
            antibody D44.1 and the crystal structure of design D44.1<sup
              >des</sup
            >
            (PDB entries: 1MLC and 6GC2, respectively) showed improved
            interactions across the interface and likely increased backbone
            rigidity. (<strong>b</strong>) SPR kinetic analysis of hen egg-white
            lysozyme (HEL) binding with threefold dilutions of HEL from a
            maximal concentration of 333 nM for D44.1 and 111 nM for D44.1<sup
              >des</sup
            >
            (kinetic fits shown in gray). D44.1 exhibited <em>k</em
            ><sub><em>a</em></sub> = 1.5 * 10<sup>5</sup>
            M<sup>-1</sup>s<sup>-1</sup>, <em>k</em><sub><em>d</em></sub> =
            0.021 s<sup>-1</sup>, and <em>K</em><sub><em>D</em></sub> = 137 nM.
            D44.1<sup>des</sup> exhibited <em>k</em><sub><em>a</em></sub> = 5.3
            * 10<sup>4</sup> M<sup>-1</sup>s<sup>-1</sup>, <em>k</em
            ><sub><em>d</em></sub> = 7.9 * 10<sup>−4</sup> s<sup>-1</sup>, and
            <em>K</em><sub><em>D</em></sub> = 15 nM (<strong>c &amp; d</strong>)
            Thermal denaturation and temperature of aggregation onset,
            respectively, of D44.1 and D44.1<sup>des</sup> formatted as Fabs
            using microscale thermophoresis. (<strong>e</strong>) A potential
            molecular explanation for improved affinity. The unbound (cyan) and
            bound (gray) structures of D44.1 (PDB entries: 1MLB and 1MLC,
            respectively) exhibit a different H2 backbone conformation; the
            former sterically hinders lysozyme binding. The high-affinity
            anti-lysozyme antibody F10.6.6 in its unbound form (PDB entry: 2Q76;
            orange) and D44.1<sup>des</sup> (pink) are similar to one another
            and to the bound conformation of D44.1 and are compatible with
            binding HEL. (inset) a closeup of the H2 backbone conformation
            revealing that the D44.1 H2 backbone (cyan) sterically overlaps with
            lysozyme, whereas all the other backbone conformations are
            compatible with lysozyme binding. The Trp47<sup>H</sup>Tyr mutation
            in D44.1<sup>des</sup> alters packing at the base of CDR H2 and may
            induce the observed conformational change in the design.
          </p>
        </figcaption>
      </figure>
      <p>
        We also compared the molecular structure of D44.1<sup>des</sup> to the
        unbound structure of D44.1 (PDB entry: 1MLB). The main difference
        between the two structures was localized to the backbone conformation of
        CDR H2: Whereas H2 in the unbound structure of D44.1 adopts a
        conformation that would sterically overlap with lysozyme in the bound
        structure, the H2 backbone of D44.1<sup>des</sup> moves away from this
        position such that, even in the unbound state, the design is sterically
        compatible with lysozyme binding. The H2 backbone conformation of
        D44.1<sup>des</sup> is not identical but is similar to the H2
        conformation in the bound D44.1 structure and also to the conformation
        observed in the unbound structure of the high-affinity anti-lysozyme
        antibody F10.6.6 (PDB entry: 1P2C) (<strong
          ><a href="#pcbi.1007207.g002">Fig 2E</a></strong
        >). Although it is possible that the observed conformational differences
        among the structures are due to differences in crystallographic
        conditions, we note that the mutation Trp47<sup>H</sup>Tyr in D44.1<sup
          >des</sup
        >
        is incompatible with the observed H2 conformation in the unbound state
        of D44.1 and may induce the observed change in the design’s backbone
        conformation. Hence, the structure-based analysis suggested that the
        design of the vL-vH interface based on the bound antibody structure
        might increase the compatibility of the CDR backbones for the ligand
        while simultaneously improving stability.
      </p>
      <h2 id="computational-mutation-tolerance-mapping">
        Computational mutation-tolerance mapping
      </h2>
      <p>
        The successful optimization of antibody affinity and stability
        encouraged us to fully automate the design procedure, eliminating the
        requirement for experimental deep mutational scanning. We, therefore,
        sought a general computational strategy that would predict which
        mutations in the vL-vH interface were likely to enhance affinity and
        stability, with the goal of developing a general computational procedure
        for mutational-tolerance mapping. To achieve this goal, we exploited the
        large experimental dataset of the D44.1 mutational tolerance map,
        comprising 2,294 point mutations, for training. At each of the mutated
        D44.1 Fv positions, we used Rosetta to compute the changes to
        native-state energy due to each of the 19 amino acid mutations
        (ΔΔ<em>G</em>). Using a multiple-sequence alignment of homologous Fvs,
        we additionally computed each point mutation’s evolutionary-conservation
        score, as represented in a Position-Specific Scoring Matrix (PSSM)
        [<cite><a href="#pcbi.1007207.ref038">#pcbi.1007207.ref038</a></cite
        >]. These two computed parameters provide complementary predictions of
        mutational tolerance: the former predicts the impact of a mutation on
        native-state stability and the latter discriminates between
        evolutionarily tolerated mutations and those that have been purged by
        evolution. The use of these two parameters has recently led to
        substantial improvement in design accuracy in binder and enzyme design
        challenges in our laboratory [<cite
          ><a href="#pcbi.1007207.ref020">#pcbi.1007207.ref020</a></cite
        >–<cite><a href="#pcbi.1007207.ref022">#pcbi.1007207.ref022</a></cite
        >,<cite><a href="#pcbi.1007207.ref038">#pcbi.1007207.ref038</a></cite
        >–<cite><a href="#pcbi.1007207.ref043">#pcbi.1007207.ref043</a></cite
        >]. We specifically used these two parameters because they can be
        computed for any antibody given an accurate experimental or model
        structure, allowing us, in principle, to compute mutational tolerance
        maps for any antibody Fv.
      </p>
      <p>
        We systematically screened different combinations of ΔΔ<em>G</em> and
        PSSM thresholds to determine which combination optimally discriminates
        enhancing from deleterious mutations as observed in the experimental
        mutational-tolerance map of D44.1. We defined the prediction
        true-positive rate (TPR) as the proportion of correctly predicted
        affinity-enhancing mutations (&gt;1.5-fold enrichment according to deep
        mutational scanning) and the true-negative rate (TNR) as the proportion
        of correctly predicted deleterious ones (enrichment ratio &lt;1). The
        resulting phase space of (PSSM, ΔΔ<em>G</em>) thresholds revealed an
        expected tradeoff, wherein high TNR came at the cost of low TPR, and
        <em>vice versa</em> (<strong
          ><a href="#pcbi.1007207.g003">Fig 3A</a></strong
        >). The likelihood of obtaining a multipoint mutant without a single
        deleterious mutation can be roughly approximated by TNR<sup
          ><em>n</em></sup
        >, where <em>n</em> is the number of mutations. Given the large size of
        the vL-vH interface (20–30 positions [<cite
          ><a href="#pcbi.1007207.ref044">#pcbi.1007207.ref044</a></cite
        >]), we aimed for a large maximum number of mutations in each multipoint
        mutant (<em>n</em> = 10) and therefore selected a stringent cutoff TNR =
        94%, providing a rough estimate that 50% of designs with ten mutations
        would not contain a single deleterious mutation (<strong
          ><a href="#pcbi.1007207.g003">Fig 3B</a></strong
        >). At this high TNR, the TPR is only 40%, reflecting the challenging
        tradeoff in the design of multipoint variants. We anticipate that in
        certain applications, such as in the design of improved antibodies for
        therapeutic application, a smaller number of mutations may be preferred.
        In such cases, a lower TNR and therefore a higher TPR may be
        implemented, and
        <strong><a href="#pcbi.1007207.g003">Fig 3C</a></strong> provides a
        guide for choosing different (PSSM, ΔΔ<em>G</em>) thresholds.
        Instructions for computing a mutation-tolerance map based on any
        structure of an antibody Fv are available as Supplemental Data, and the
        AbLIFT web server enables user control of these parameters.
      </p>
      <figure id="pcbi.1007207.g003" title="Fig 3">
        <img src="article-antibodies.html.media/g003.png" itemprop="image" />
        <figcaption>
          <h2
            id="mutational-tolerance-mapping-by-rosetta-atomistic-energy-calculations-δδg-and-evolutionary-conservation-scores-pssm"
          >
            Mutational-tolerance mapping by Rosetta atomistic energy
            calculations (ΔΔ<em>G</em>) and evolutionary-conservation scores
            (PSSM).
          </h2>
          <p>
            (<strong>a</strong>) Systematic analysis of combinations of PSSM and
            ΔΔ<em>G</em> thresholds reveals an expected tradeoff in prediction
            accuracy of mutational tolerance. Each combination of thresholds
            (-10≤PSSM≤10; -10≤ΔΔ<em>G</em>≤20 Rosetta energy units, R.e.u.)
            results in a different fraction of correctly predicted enhancing or
            deleterious mutations (true-positive rate [TPR] and true-negative
            rate [TNR], respectively) observed in the deep mutational scanning
            data of D44.1. (<strong>b</strong>) All (PSSM, ΔΔ<em>G</em>)
            combinations are plotted with their TPR and TNR values, and the
            Pareto-optimal front is indicated in orange. Several combinations of
            (PSSM, ΔΔ<em>G</em>) thresholds are indicated by blue triangles.
            (<strong>c</strong>) The thresholds (PSSM≥-1, ΔΔ<em>G</em>≤+1
            R.e.u.) result in a TNR of 94% and TPR of 40% and were used in
            subsequent design calculations. Optimal ΔΔ<em>G</em> cutoffs may
            vary depending on the energy function and the relaxation protocol.
            For details on these choices, see <a href="#sec007">Methods</a>.
          </p>
        </figcaption>
      </figure>
      <h2 id="automated-affinity-and-stability-design-in-the-vl-vh-interface">
        Automated affinity and stability design in the vL-vH interface
      </h2>
      <p>
        We next sought to develop a general and fully automated design protocol
        for improving molecular interactions across the vL-vH interface. AbLIFT
        starts by computing a mutational-tolerance map at the vL-vH interface
        using the approach described above; it then exhaustively enumerates the
        multipoint combinations of tolerated mutations; ranks them by energy,
        and selects low-energy variants for experimental testing. This algorithm
        resembles our recently described FuncLib method for designing
        functionally diverse enzyme repertoires [<cite
          ><a href="#pcbi.1007207.ref041">#pcbi.1007207.ref041</a></cite
        >], with the key differences that AbLIFT is applied to the core of
        obligatory binding surfaces rather than to solvent-exposed surfaces and
        most importantly, AbLIFT does not require an initial design round of
        protein stabilization.
      </p>
      <p>
        To validate AbLIFT, we chose two antibodies as subjects for design: the
        synthetic antibody G6, which targets human Vascular-Endothelial Growth
        Factor (VEGF) [<cite
          ><a href="#pcbi.1007207.ref045">#pcbi.1007207.ref045</a></cite
        >], and an engineered variant of the 492.1 antibody, designated h492.1,
        which targets human Quiescin Sulfhydryl Oxidase 1 (QSOX1). QSOX1 is a
        multi-domain disulfide-catalyst that is overproduced in tumors [<cite
          ><a href="#pcbi.1007207.ref046">#pcbi.1007207.ref046</a></cite
        >] and is a potential drug target [<cite
          ><a href="#pcbi.1007207.ref047">#pcbi.1007207.ref047</a></cite
        >,<cite><a href="#pcbi.1007207.ref048">#pcbi.1007207.ref048</a></cite
        >]. These antibodies are unrelated to D44.1 or to one another and are
        the products of protein engineering. G6 is widely used in animal studies
        and resulted from a phage-displayed synthetic Fab library of the light
        chain with a heavy chain sequence of an anti-mVEGF antibody (<em>K</em
        ><sub><em>D</em></sub> approximately 1 nM) [<cite
          ><a href="#pcbi.1007207.ref049">#pcbi.1007207.ref049</a></cite
        >]. The h492.1 antibody was obtained by fusing the variable domains from
        the high-affinity (<em>K</em><sub><em>D</em></sub> approximately 1 nM)
        QSOX1-inhibiting murine antibody 492.1 onto a human IgG scaffold.
        Following this fusion, h492.1 could not be expressed to detectable
        levels in a recombinant cultured human cell system, frustrating its
        further development. Thus, with these two targets, we sought to test the
        ability of AbLIFT to optimize high-affinity antibodies that resulted
        from conventional antibody-engineering procedures, whether well-behaved
        ones (G6) or ones that showed low (or no) detectable expression levels
        (h492.1).
      </p>
      <p>
        The computed mutational-tolerance map of G6 (starting from its bound
        structure, PDB entry 2FJG) at 30 vL-vH interface positions defined 26
        affinity-enhancing mutations at 11 positions. To achieve significant
        improvement of vL-vH interface packing, we sought to design multipoint
        mutants with 4–10 mutations relative to G6, resulting in a tolerated
        sequence space of 203,835 unique multipoint mutants. All multipoint
        mutants were modeled in Rosetta, including by a backbone and side-chain
        minimization step, which is essential for enabling cavity-filling
        small-to-large mutations [<cite
          ><a href="#pcbi.1007207.ref050">#pcbi.1007207.ref050</a></cite
        >,<cite><a href="#pcbi.1007207.ref051">#pcbi.1007207.ref051</a></cite
        >], and the models were then ranked by energy. 53% of the mutants
        (&gt;100,000) exhibited energies as favorable as or better than the
        G6-bound antibody. Therefore, although the exhaustive enumeration of
        this large number of mutants is computationally demanding (approximately
        6,000-CPU hours), the very large number of potentially improved designs
        makes a compelling case for exhaustive enumeration and ranking of
        variants within the tolerated sequence space. Furthermore, the computed
        mutational-tolerance map focuses exhaustive enumeration on a subset of
        stable multipoint mutants within the vast hypothetical sequence space of
        mutants at the vL-vH interface (20<sup>30</sup> = 10<sup>39</sup> unique
        sequences), &gt;99% of which are predicted to have reduced stability
        compared to the parental antibody (<strong
          ><a href="#pcbi.1007207.s003">S3 Fig</a></strong
        >).
      </p>
      <p>
        We clustered the designs, eliminating ones that had fewer than four
        mutations relative to one another and selected the 18 lowest-energy ones
        for experimental testing. The designs were formatted as scFvs, and their
        binding signals relative to the G6 antibody were first qualitatively
        measured at 8 nM VEGF concentration using yeast display [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >] (<strong><a href="#pcbi.1007207.g004">Fig 4A</a></strong
        >). Encouragingly, seven designs (approximately 40%) showed comparable
        or higher binding signal at this concentration. The best two designs,
        G6<sup>des1</sup> and G6<sup>des13</sup>, were expressed as Fabs. When
        subjected to Ni-NTA purification, G6 exhibited multiple bands,
        indicative of sample heterogeneity, whereas, remarkably, both designs
        eluted mostly in the size expected for a Fab (<strong
          ><a href="#pcbi.1007207.s004">S4A and S4B Fig</a></strong
        >) [<cite><a href="#pcbi.1007207.ref052">#pcbi.1007207.ref052</a></cite
        >].
      </p>
      <figure id="pcbi.1007207.g004" title="Fig 4">
        <img src="article-antibodies.html.media/g004.png" itemprop="image" />
        <figcaption>
          <h2
            id="fully-automated-antibody-stability-and-affinity-optimization-using-ablift"
          >
            Fully automated antibody stability and affinity optimization using
            AbLIFT.
          </h2>
          <p>
            (<strong>a</strong>) G6 and 18 low-energy designs, each encoding
            4–10 mutations relative to G6 (number of mutations is indicated
            above the bars) were tested for binding using yeast display at 8 nM
            VEGF concentration, resulting in seven designs that showed
            comparable or higher binding signal compared to G6. G6<sup
              >des1</sup
            >
            and G6<sup>des13</sup> were chosen for further characterization
            (colored in blue and orange, respectively). (<strong>b</strong>) SPR
            kinetic analysis of VEGF binding with twofold dilutions from a
            maximal concentration of 100 nM by G6, G6<sup>des1</sup>, and G6<sup
              >des13</sup
            >
            Fabs demonstrated faster binding on-rate in the designs (<em>k</em
            ><sub><em>a</em></sub> = 2.3 * 10<sup>5</sup>
            M<sup>-1</sup>s<sup>-1</sup>, 3.27 * 10<sup>5</sup>
            M<sup>-1</sup>s<sup>-1</sup> and 5.3 * 10<sup>5</sup>
            M<sup>-1</sup>s<sup>-1</sup>, respectively). G6<sup>des13</sup> also
            improved binding off-rate (<em>k</em><sub><em>d</em></sub> = 3.2 *
            10<sup>−5</sup> s<sup>-1</sup> compared to 6 * 10<sup>−5</sup> s<sup
              >-1</sup
            >
            in G6), resulting in an improved dissociation constant (<em>K</em
            ><sub><em>D</em></sub> = 60 pM compared to 270 pM in G6). (<strong
              >c &amp; d</strong
            >) Thermal denaturation and temperature of aggregation onset
            experiments, respectively, using microscale thermophoresis indicated
            substantially higher apparent stability in the designs.
            (<strong>e</strong>) Computational mutation-tolerance mapping
            indicated 11 positions at the vL-vH interface of the anti-VEGF
            antibody G6 (spheres) with potentially tolerated mutations.
            Thumbnails indicate selected mutations in a model structure of
            G6<sup>des13</sup> relative to G6 (gray). (<strong>f</strong>)
            Expression levels in HEK293 cells of G6 and the designs formatted as
            IgG were measured using Western blot analysis showing approximately
            an order of magnitude improvement in IgG expression levels for the
            designs. <strong>(g)</strong> Native mass-spectrometry analysis
            exhibited higher tolerance to applied collision energy in G6<sup
              >des13</sup
            >
            compared to G6, both formatted as IgG. The error bars represent
            standard deviations inferred from three repeats.
          </p>
        </figcaption>
      </figure>
      <p>
        Next, the designs’ affinities for VEGF were determined using SPR
        (<strong><a href="#pcbi.1007207.g004">Fig 4B</a></strong
        >). Both designs improved binding on-rate, and G6<sup>des13</sup> also
        improved the off-rate, resulting in fivefold improvement in <em>K</em
        ><sub><em>D</em></sub> relative to G6. Both designs also exhibited
        substantial improvements in thermal stability and the temperature of
        aggregation onset (19° C and 10° C, respectively) (<strong
          ><a href="#pcbi.1007207.g004">Fig 4C and 4D</a></strong
        >). We examined the model structure of G6<sup>des13</sup>, which
        comprised six mutations at the vL-vH interface relative to G6, finding
        that the mutations were likely to improve the interface through backbone
        rigidification and the introduction of a new buried polar hydrogen-bond
        network (<strong><a href="#pcbi.1007207.g004">Fig 4E</a></strong
        >). Such cooperative interaction networks do not typically arise in
        conventional antibody affinity-maturation processes (either in nature or
        the laboratory), which select mutations in a stepwise manner and are
        therefore biased towards additive rather than cooperative multipoint
        mutations. Introducing accurate new polar interaction networks is also a
        fundamental challenge for computational design [<cite
          ><a href="#pcbi.1007207.ref053">#pcbi.1007207.ref053</a></cite
        >,<cite><a href="#pcbi.1007207.ref054">#pcbi.1007207.ref054</a></cite
        >] and the use of evolutionary constraints during design has recently
        been shown to overcome this challenge [<cite
          ><a href="#pcbi.1007207.ref042">#pcbi.1007207.ref042</a></cite
        >].
      </p>
      <p>
        We next tested the stability and expressibility of the VEGF designs
        formatted as full-length IgGs. We expressed G6, G6<sup>des1</sup>, and
        G6<sup>des13</sup> in HEK293 cells and found that the designs exhibited
        nearly an order of magnitude higher expression level than G6 (<strong
          ><a href="#pcbi.1007207.g004">Fig 4F</a></strong
        >). We next measured the relative stabilities of G6 and G6<sup
          >des13</sup
        >
        using native mass spectrometry [<cite
          ><a href="#pcbi.1007207.ref055">#pcbi.1007207.ref055</a></cite
        >] under reducing conditions by titrating the collision energy (<strong
          ><a href="#pcbi.1007207.g004">Fig 4G</a></strong
        >). We found that G6 IgG disassembly started at lower collision energy
        compared to G6<sup>des13</sup>, indicative of the design’s higher
        stability (<strong><a href="#pcbi.1007207.s005">S5 Fig</a></strong
        >). We, therefore, concluded that AbLIFT could substantially improve
        expressibility, stability, and affinity, regardless of whether the
        antibody was formatted as Fab or IgG.
      </p>
      <p>
        We applied the same computational strategy to h492.1, in which the Fv
        was derived from a murine antibody and the constant regions were derived
        from human IgG1. Since h492.1 failed to show detectable expression in
        HEK293 cell cultures, we started the computational design from the
        structure of the murine 492.1 parental antibody in complex with QSOX1
        (PDB entry: 4IJ3) [<cite
          ><a href="#pcbi.1007207.ref047">#pcbi.1007207.ref047</a></cite
        >]. We selected the 20 lowest-energy, sequence-clustered AbLIFT designs,
        fused them to human IgG1 constant domains and subjected them to
        HEK293-expression screening from crude cell lysate supernatant. Dot-blot
        analysis showed detectable expression levels for all 20 designs, in
        clear contrast with the lack of detectable expression for h492.1
        (<strong><a href="#pcbi.1007207.g005">Fig 5A</a></strong
        >). We further quantitated expression levels using Western blot,
        revealing substantial variation in the expression levels among the
        designs (<strong><a href="#pcbi.1007207.g005">Fig 5B</a></strong
        >). In parallel, we examined the levels of QSOX1 inhibition by the 20
        designs, finding that 50% showed high levels of QSOX1 inhibition
        (<strong><a href="#pcbi.1007207.s006">S6 Fig</a></strong
        >). Based on activities and expression levels, we selected h492.1<sup
          >des3</sup
        >
        and h492.1<sup>des18</sup> for further analysis. These designs were
        purified and added to QSOX1 activity assays to test for inhibition.
        h492.1<sup>des18</sup> showed comparable inhibitory levels to the murine
        parent antibody when provided at equimolar amounts to a typical
        physiological concentration of QSOX1 (25 nM) as found in human serum
        (<strong><a href="#pcbi.1007207.g005">Fig 5C</a></strong
        >) [<cite><a href="#pcbi.1007207.ref056">#pcbi.1007207.ref056</a></cite
        >]. This analysis demonstrated that h492.1<sup>des18</sup> almost
        completely recovered the activity of the parental antibody while gaining
        high expression levels (approximately 75 mg/L supernatant). Structural
        analysis indicated that this design improved packing at the vL-vH
        interface (<strong><a href="#pcbi.1007207.g005">Fig 5D</a></strong
        >), demonstrating that in some cases optimizing this region could have a
        dramatic effect on the expression levels of engineered antibodies.
      </p>
      <figure id="pcbi.1007207.g005" title="Fig 5">
        <img src="article-antibodies.html.media/g005.png" itemprop="image" />
        <figcaption>
          <h2
            id="substantial-increase-in-antibody-expression-yields-following-ablift-design"
          >
            Substantial increase in antibody expression yields following AbLIFT
            design.
          </h2>
          <p>
            (<strong>a</strong>) Dot blot analysis showed no detectable
            expression for h492.1 in HEK293 cells, whereas all 20 designs showed
            detectable levels of expression. (<strong>b</strong>) Relative
            expression levels of the 20 designs using Western blot analysis.
            h492.1<sup>des3</sup> and h492.1<sup>des18</sup> showed high
            expression and were selected for further analysis.
            (<strong>c</strong>) QSOX1 inhibitory activity assay using the
            parental 492.1 antibody and two designs. The inhibitory activity was
            measured for each antibody in a sulfhydryl oxidase assay using a
            physiological concentration of QSOX1 (25 nM). h492.1<sup>des18</sup>
            showed comparable inhibitory activity relative to the parental
            antibody, with only a slight decrease when provided at
            sub-stoichiometric amounts (10 nM). (<strong>d</strong>) The
            structural context of mutations in h492.1<sup>des18</sup> (color)
            relative to the experimental structure of 492.1 (gray). Spheres
            indicate the locations of the mutations, and the thumbnail shows two
            of the four designed mutations, which improve interchain packing and
            rigidify the backbone at the vL-vH interface according to the model
            structure.
          </p>
        </figcaption>
      </figure>
      <p>
        Finally, we asked whether there were any sequence features in common
        among the designs (<strong
          ><a href="#pcbi.1007207.s009">S3</a> and
          <a href="#pcbi.1007207.s010">S4</a> Tables</strong
        >). Strikingly, position 43<sup>L</sup> (Chothia numbering) was mutated
        to Pro in D44.1<sup>des</sup> and in &gt;60% of the G6 and h492.1
        designs. Position 43<sup>L</sup> is located in a tight turn that
        connects two neighboring β strands, away from the CDRs, but Pro is not
        the consensus identity at this position (Ala and Ser are preferred).
        Furthermore, mutations at this position may have an important effect on
        the rigid-body angle formed by the variable light and heavy domains
        [<cite><a href="#pcbi.1007207.ref044">#pcbi.1007207.ref044</a></cite
        >,<cite><a href="#pcbi.1007207.ref057">#pcbi.1007207.ref057</a></cite
        >], and it is, therefore, unlikely that this mutation would universally
        improve antibody stability and affinity. Other than this mutation to
        Pro, we did not observe common sequence features among the designs.
        Overlapping but non-identical sets of positions were varied in each of
        the three case studies presented here, and the mutations at aligned
        positions were dissimilar. We, therefore, concluded that the designs
        improved interactions across the vL-vH interface through a variety of
        mechanisms that depended on the specific molecular structure of the
        parental antibodies.
      </p>
      <h1 id="discussion">Discussion</h1>
      <p>
        Our study demonstrates that improved interactions across the vL-vH
        interface may result in substantial optimization of a range of essential
        parameters for antibody development, including expressibility,
        stability, and affinity. The automated AbLIFT strategy enables the
        design of cooperative networks of multipoint mutations in the antibody
        core that are likely to be inaccessible to experimental affinity
        maturation processes since these latter methods select mutations in a
        stepwise manner. Since AbLIFT impacts the antibody core and does not
        alter the structure of the antigen-binding site, the designed mutations
        cooperate with surface mutations identified through conventional
        antibody-engineering processes to further increase affinity and
        stability. AbLIFT may be particularly beneficial in antibodies, such as
        G6 and h492.1, which were the product of antibody-engineering approaches
        that might compromise antibody structural integrity, resulting in
        reduced affinity or stability. Moreover, antibody structure-prediction
        methods now often produce atomically accurate models at the vL-vH
        interface (though still not at the CDR H3) [<cite
          ><a href="#pcbi.1007207.ref058">#pcbi.1007207.ref058</a></cite
        >–<cite><a href="#pcbi.1007207.ref060">#pcbi.1007207.ref060</a></cite
        >], suggesting that by restricting design to the framework regions,
        AbLIFT may in some cases enable antibody optimisation even in the
        absence of an experimental structure. We note, however, that AbLIFT
        considers only phylogenetic information and molecular energetics and
        disregards immunogenicity, which may be an important consideration in
        antibodies developed for clinical use. To address this concern, the
        AbLIFT web server enables complete control over the design sequence
        space and can be used to eliminate mutations with immunogenic potential.
      </p>
      <p>
        The surprisingly broad ability of vL-vH design to optimize antibody
        properties is consistent with the Colman interface-adaptor hypothesis,
        according to which the formation of the Fv from two chains renders it
        flexible [<cite
          ><a href="#pcbi.1007207.ref034">#pcbi.1007207.ref034</a></cite
        >]. According to this hypothesis, Fv flexibility is likely to be an
        adaptive property selected by evolution to broaden molecular recognition
        by each individual antibody to a range of antigens through induced fit
        or conformational selection [<cite
          ><a href="#pcbi.1007207.ref061">#pcbi.1007207.ref061</a></cite
        >], thereby solving the conundrum of how a large but finite antibody
        repertoire could recognize a potentially infinite range of antigens
        [<cite><a href="#pcbi.1007207.ref062">#pcbi.1007207.ref062</a></cite
        >]. Flexibility, however, might come at a cost, since an Fv that
        exhibits flexible vL-vH pairing may occupy multiple molecular states
        that compete with the binding-competent state, thus lowering
        antigen-binding affinity. Flexibility may moreover result in misfolding
        or transient dissociation of the two variable chains, resulting in
        terminal aggregation or degradation by the cellular proteostasis
        machinery, thereby lowering expression yields. In extreme cases, poorly
        defined packing at the vL-vH interface can lead to substantial
        rearrangements of the antibody variable domain during binding [<cite
          ><a href="#pcbi.1007207.ref063">#pcbi.1007207.ref063</a></cite
        >], and such rearrangements could lower antigen-binding affinity and
        specificity. Therefore, while the interface-adaptor hypothesis neatly
        explains why flexibility at the vL-vH interface is advantageous in early
        steps of antibody selection, broad specificity and marginal vL-vH
        interface stability become liabilities in later stages of antibody
        development into research or therapeutic tools. We anticipate that
        AbLIFT will have a wide scope to automatically and reliably improve
        stability, solubility, expressibility, affinity, and structural
        integrity in numerous antibodies in which these important properties are
        compromised.
      </p>
      <h1 id="methods">Methods</h1>
      <h2 id="d441-genetic-library-construction">
        D44.1 genetic library construction
      </h2>
      <p>
        Forward and reverse primers with the degenerate codon NNS were generated
        for all 135 positions on the Fv of D44.1, essentially as described
        [<cite><a href="#pcbi.1007207.ref064">#pcbi.1007207.ref064</a></cite
        >]. Primers were ordered from Sigma (Sigma-Aldrich, Rehovot, Israel) and
        were used to introduce all possible amino acids per position by
        QuickChange mutagenesis [<cite
          ><a href="#pcbi.1007207.ref065">#pcbi.1007207.ref065</a></cite
        >]. Next, the PCR product of each position was transformed into yeast
        (EBY100 cells) and plated on SD-Trp as described [<cite
          ><a href="#pcbi.1007207.ref066">#pcbi.1007207.ref066</a></cite
        >]. Briefly, plates with more than 400 colonies were scraped with 1 ml
        SDCAA, 50 μl was added to 5 ml SDCAA tube and cells were then grown at
        30°C overnight. The point mutants were split into six libraries,
        corresponding to positions that were at most 130 bp apart from one
        another to enable deep mutational scanning using 150 bp reads.
      </p>
      <h2 id="yeast-surface-display-selection-for-libraries">
        Yeast surface display selection for libraries
      </h2>
      <p>
        Yeast-display experiments were conducted essentially as described [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >]. Briefly, yeast cells were grown in selective medium SDCAA overnight
        at 30°C. The cells were then resuspended in 10 ml induction medium and
        incubated at 20°C for 20 h. 10<sup>7</sup> cells were then used for
        yeast-cell surface display experiments: cells were subjected to primary
        antibody (mouse monoclonal IgG1 anti-c-Myc (9E10) sc-40, Santa Cruz
        Biotechnology) for expression monitoring and biotinylated ligand at 90
        nM lysozyme (GeneTex) in PBS-F for 30 min at room temperature. The cells
        then underwent a second staining with fluorescently labeled secondary
        antibody (AlexaFluor488—goat-anti-mouse IgG1 (Life Technologies) for
        scFv labeling, Streptavidin-APC (SouthernBiotech) for ligand labeling)
        for 10 min at 4°C. Next, the cell fluorescence was measured and cells
        were collected under sorting conditions for expression and top 15%
        binders. The selection gates were calibrated using the wild-type scFv
        D44.1 and these gates were subsequently applied to the library
        constructs. Following fluorescence-activated cell sorting (FACS), cells
        were grown in SDCAA for 1–2 days and plasmids were extracted using
        Zymoprep Yeast Plasmid Miniprep II kit (Zymo Research).
      </p>
      <h2 id="yeast-surface-display-of-anti-vegf-scfvs">
        Yeast surface display of anti-VEGF scFvs
      </h2>
      <p>
        18 designs of improved binding affinity antibodies against VEGF and the
        wild-type G6 Fvs were ordered from Twist Biosciences as scFvs. These, as
        described above, were amplified by PCR and cloned into pCTCon2 using
        homologous recombination in yeast [<cite
          ><a href="#pcbi.1007207.ref066">#pcbi.1007207.ref066</a></cite
        >]. The plasmids were extracted by Zymoprep kit II, transformed into
        bacteria for sequence validation and verified clones were transformed to
        yeast for display [<cite
          ><a href="#pcbi.1007207.ref003">#pcbi.1007207.ref003</a></cite
        >]. The wild-type and designed antibodies were tested for binding by
        flow cytometry with 8 nM biotinylated VEGF (Recombinant Human VEGF 165,
        Biotinylated Protein R&amp;D systems).
      </p>
      <h2 id="dna-preparation-for-deep-sequencing">
        DNA preparation for deep sequencing
      </h2>
      <p>
        To connect the DNA adaptors for deep sequencing, the plasmids extracted
        from the libraries were amplified using Phusion High-Fidelity DNA
        Polymerase (ThermoFisher) in a two-step PCR protocol.
      </p>
      <p>PCR 1:</p>
      <p>(barcode: CTCTTTCCCTACACGACGCTCTTCCGATCT)</p>
      <p>
        &gt;forward (seg1):<strong>&lt;barcode&gt;</strong>AGGGTCGGCTAGCCATATG
      </p>
      <p>
        &gt;forward
        (seg2):<strong>&lt;barcode&gt;</strong>GGATCGAATGGGTTAAACAACGT
      </p>
      <p>
        &gt;forward (seg3):<strong>&lt;barcode&gt;</strong>ACACCTCCTCTAACACCGC
      </p>
      <p>&gt;forward (seg4):<strong>&lt;barcode&gt;</strong>CTGGTGGCGGTGGCTC</p>
      <p>
        &gt;forward (seg5):<strong>&lt;barcode&gt;</strong>GCCGTGCGTCTCAGTCTATT
      </p>
      <p>
        &gt;forward (seg6): <strong>&lt;barcode&gt;</strong>CCATCTCGTTTCTCCGGC
      </p>
      <p>
        &gt;reverse:
        <strong>CTGGAGTTCAGACGTGTGCTCTTCCGATCT</strong>GGATCGAATGGGTTAAACAACGT
      </p>
      <p>
        The PCR product for each population (expressed and top 15% of binders
        for each of the six libraries) was cleaned using Agencourt AMPure XP
        (Beckman Coulter, Inc.) and 1 μl from a 1:10 dilution was taken to the
        next PCR step for index labeling using KAPA Hifi DNA-polymerase (Kapa
        Biosystems, London, England):
      </p>
      <p>&gt;forward: AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC</p>
      <p>
        &gt;reverse:
        CAAGCAGAAGACGGCATACGAGAT&lt;index&gt;GTGACTGGAGTTCAGACGTGTGC
      </p>
      <p>Top 15%—index: CAATAGTC</p>
      <p>Expressed—index: TTGAGCCT</p>
      <p>
        All the primers were ordered as PAGE-purified oligos. The concentration
        of the PCR product was measured using Qu-bit assay (Life Technologies,
        Grand Island, New York).
      </p>
      <h2 id="deep-sequencing-runs">Deep-sequencing runs</h2>
      <p>
        DNA samples were run on an Illumina MiSeq using 150-bp paired-end kits.
        The FASTQ sequence files were obtained for each run, and customized
        scripts were used to generate the selection heat maps from the data as
        previously described [<cite
          ><a href="#pcbi.1007207.ref064">#pcbi.1007207.ref064</a></cite
        >]. Briefly, the script starts by translating the DNA sequence to amino
        acid sequence; eliminates sequences that harbor more than one amino acid
        mutation relative to wild type and also sequences that failed the QC
        test; counts each variant in each population; and eliminates variants
        with fewer than 100 counts in the reference population (to reduce
        statistical uncertainty).
      </p>
      <h2 id="sequencing-analysis">Sequencing analysis</h2>
      <p>
        To derive the mutational landscapes we compute the frequency
        <em>P<sup>i,j</sup></em> of each mutant relative to wild-type in the
        selected and reference pools, where <em>i</em> is the position and
        <em>j</em> is the substitution, relative to wild-type:
        <img src="article-antibodies.html.media/e001.png" itemprop="image" />(Eq
        1) where count is the number of reads for each mutant. The selection
        coefficients are then computed as the ratio:
        <img src="article-antibodies.html.media/e002.png" itemprop="image" />(Eq
        2) where <em>selected</em> refers to the top 15% binding population and
        reference refers to the reference population (Expression). The resulting
        <em>S<sup>i,j</sup></em> values are then transformed to
        <em>−ln</em> enrichment values:
        <img src="article-antibodies.html.media/e003.png" itemprop="image" />(Eq
        3)
      </p>
      <math>
        <mml:msup>
          <mml:mrow>
            <mml:mi>P</mml:mi>
          </mml:mrow>
          <mml:mrow>
            <mml:mi>i</mml:mi>
            <mml:mo>,</mml:mo>
            <mml:mi>j</mml:mi>
          </mml:mrow>
        </mml:msup>
        <mml:mo>=</mml:mo>
        <mml:mfrac>
          <mml:mrow>
            <mml:msup>
              <mml:mrow>
                <mml:mi mathvariant="normal">c</mml:mi>
                <mml:mi mathvariant="normal">o</mml:mi>
                <mml:mi mathvariant="normal">u</mml:mi>
                <mml:mi mathvariant="normal">n</mml:mi>
                <mml:mi mathvariant="normal">t</mml:mi>
              </mml:mrow>
              <mml:mrow>
                <mml:mi>i</mml:mi>
                <mml:mo>,</mml:mo>
                <mml:mi>j</mml:mi>
              </mml:mrow>
            </mml:msup>
          </mml:mrow>
          <mml:mrow>
            <mml:msub>
              <mml:mrow>
                <mml:mi>c</mml:mi>
                <mml:mi>o</mml:mi>
                <mml:mi>u</mml:mi>
                <mml:mi>n</mml:mi>
                <mml:mi>t</mml:mi>
              </mml:mrow>
              <mml:mrow>
                <mml:mi>w</mml:mi>
                <mml:mi>i</mml:mi>
                <mml:mi>l</mml:mi>
                <mml:mi>d</mml:mi>
                <mml:mo>−</mml:mo>
                <mml:mi>t</mml:mi>
                <mml:mi>y</mml:mi>
                <mml:mi>p</mml:mi>
                <mml:mi>e</mml:mi>
              </mml:mrow>
            </mml:msub>
          </mml:mrow>
        </mml:mfrac> </math
      ><math>
        <mml:msup>
          <mml:mrow>
            <mml:mi>S</mml:mi>
          </mml:mrow>
          <mml:mrow>
            <mml:mi>i</mml:mi>
            <mml:mo>,</mml:mo>
            <mml:mi>j</mml:mi>
          </mml:mrow>
        </mml:msup>
        <mml:mo>=</mml:mo>
        <mml:mfrac>
          <mml:mrow>
            <mml:msub>
              <mml:mrow>
                <mml:mo stretchy="false">(</mml:mo>
                <mml:msup>
                  <mml:mrow>
                    <mml:mi>P</mml:mi>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mi>i</mml:mi>
                    <mml:mo>,</mml:mo>
                    <mml:mi>j</mml:mi>
                  </mml:mrow>
                </mml:msup>
                <mml:mo stretchy="false">)</mml:mo>
              </mml:mrow>
              <mml:mrow>
                <mml:mi>s</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>l</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>c</mml:mi>
                <mml:mi>t</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>d</mml:mi>
              </mml:mrow>
            </mml:msub>
          </mml:mrow>
          <mml:mrow>
            <mml:msub>
              <mml:mrow>
                <mml:mo stretchy="false">(</mml:mo>
                <mml:msup>
                  <mml:mrow>
                    <mml:mi>P</mml:mi>
                  </mml:mrow>
                  <mml:mrow>
                    <mml:mi>i</mml:mi>
                    <mml:mo>,</mml:mo>
                    <mml:mi>j</mml:mi>
                  </mml:mrow>
                </mml:msup>
                <mml:mo stretchy="false">)</mml:mo>
              </mml:mrow>
              <mml:mrow>
                <mml:mi>r</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>f</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>r</mml:mi>
                <mml:mi>e</mml:mi>
                <mml:mi>n</mml:mi>
                <mml:mi>c</mml:mi>
                <mml:mi>e</mml:mi>
              </mml:mrow>
            </mml:msub>
          </mml:mrow>
        </mml:mfrac> </math
      ><math>
        <mml:mo>−</mml:mo>
        <mml:mi>l</mml:mi>
        <mml:mi>n</mml:mi>
        <mml:mo>(</mml:mo>
        <mml:msup>
          <mml:mrow>
            <mml:mi>S</mml:mi>
          </mml:mrow>
          <mml:mrow>
            <mml:mi>i</mml:mi>
            <mml:mo>,</mml:mo>
            <mml:mi>j</mml:mi>
          </mml:mrow>
        </mml:msup>
        <mml:mo>)</mml:mo>
      </math>
      <h2 id="computational-methods">Computational methods</h2>
      <p>
        All Rosetta design simulations used git version
        fb77c732b4f08b6c30572a2ef7760ad3bb4535ca of the Rosetta biomolecular
        modeling software, which is freely available to academics at
        <a href="http://www.rosettacommons.org/"
          >http://www.rosettacommons.org</a
        >. Position-Specific Scoring Matrices (PSSM) for designed antibodies
        against VEGF (PDB: 2FJG) and against QSOX1 (PDB: 4IJ3) were collected as
        described in ref. [<cite
          ><a href="#pcbi.1007207.ref038">#pcbi.1007207.ref038</a></cite
        >] and are distributed with the Rosetta release. RosettaScripts [<cite
          ><a href="#pcbi.1007207.ref067">#pcbi.1007207.ref067</a></cite
        >] and command lines are available in Supplemental Data. As in the
        <em>AbDesign</em> method [<cite
          ><a href="#pcbi.1007207.ref038">#pcbi.1007207.ref038</a></cite
        >], separate PSSMs were generated for CDRs 3 and for CDRs 1, 2 and the
        framework by aligning structurally similar antibodies in the PDB and
        selecting only sequences that did not exhibit gaps relative to the query
        sequence; furthermore, a strict cutoff of ≤ 0.5 Å backbone-carbonyl rmsd
        was used to eliminate structurally divergent sequences. Thus, the PSSMs
        were only based on structural considerations and not on sequence
        homology or source organism.
      </p>
      <p>
        We refined each bound PDB structure by four iterations of side-chain
        packing and side-chain and backbone minimization, saving the
        minimum-energy structure. Computational mutation scanning was applied to
        the refined structure using the FilterScan filter in Rosetta [<cite
          ><a href="#pcbi.1007207.ref024">#pcbi.1007207.ref024</a></cite
        >]. At every position, each allowed mutation (that is, every amino acid
        identity with PSSM score ≥-1) was modeled singly against the background
        of the refined structure. Protein side chains within 8 Å of the modeled
        mutation were repacked, and side-chain and constrained backbone
        minimization were used to accommodate the mutation. The energy
        difference between the refined structure and the optimized configuration
        of the single-point mutant was calculated using the talaris2014 energy
        function [<cite
          ><a href="#pcbi.1007207.ref068">#pcbi.1007207.ref068</a></cite
        >]. The energy threshold used to define the tolerated mutation space was
        +1 R.e.u. We next enumerated all possible combinations of mutations
        against VEGF (203,835 models) and against QSOX1 (491,235 models),
        modeled them in Rosetta and relaxed them by sidechain packing and
        sidechain, backbone and rigid-body minimization with harmonic backbone
        coordinate restraints. Designs were ranked based on their energy and the
        top 18 designs differing by 4–10 mutations relative to one another
        (VEGF) (<strong><a href="#pcbi.1007207.s008">S2 Table</a></strong
        >) and the top 20 designs differing by 3–14 mutations relative to one
        another (QSOX1) (<strong
          ><a href="#pcbi.1007207.s009">S3 Table</a></strong
        >) were selected for experimental characterization.
      </p>
      <h2 id="the-ablift-web-server">The AbLIFT web-server</h2>
      <p>
        The web-server implements several improvements relative to the method
        used to design the G6 and h492.1 variants [<cite
          ><a href="#pcbi.1007207.ref041">#pcbi.1007207.ref041</a></cite
        >]. In the AbLIFT web-server, the multiple-sequence alignment used to
        construct the PSSM is first filtered to eliminate all loops and
        secondary-structure elements that exhibit any gaps relative to the query
        sequence. Furthermore, the web-server implements more accurate atomistic
        scoring and enables greater user control: it uses the recent Rosetta
        energy function ref15 [<cite
          ><a href="#pcbi.1007207.ref069">#pcbi.1007207.ref069</a></cite
        >] with improved electrostatics and solvation potentials relative to the
        previous Rosetta energy function talaris and allows the user to manually
        modify the tolerated sequence space (for instance, based on prior
        experimental data or to eliminate potential immunogenic sequence
        signatures). Accordingly, ΔΔ<em>G</em> and PSSM cutoffs may be different
        from those used to in the designs described in the paper, and the web
        server provides user control over these parameters.
      </p>
      <h2 id="bacterial-expression-and-purification-d441-and-d441des">
        Bacterial expression and purification (D44.1 and D44.1<sup>des</sup>)
      </h2>
      <p>
        The design and wild-type were transformed into RH2.2 plasmid for
        expression as Fabs, where the heavy chain was N-terminally His-tagged
        and the light chain was expressed as a separate protein. Both chains
        contain a secretion sequence for direction to the periplasmic space,
        where they fold and dimerize. Restriction-free cloning was done using
        Kapa HiFi Hotstart Readymix (Kapa Biosystems) according to the
        manufacturer’s protocol.
      </p>
      <p>
        Cells were induced with 1 mM IPTG at OD600 = 0.6, transferred to 20°C,
        and harvested after 20 h. The cells were then resuspended in buffer A
        [20 mM phosphate buffer pH 6.2, 150 mM NaCl] and sonicated. The
        supernatant was harvested by centrifugation (20,000 × <em>g</em>, 1 h),
        filtered, and loaded on HiTrap TALON crude 1 ml column (GE Healthcare).
        Then it was washed with 15–20 bed volumes of buffer A, and then eluted
        with buffer B [20 mM phosphate buffer pH 6.2,150 mM NaCl, 150 mM
        imidazole]. Imidazole was removed from the eluate by dialysis against
        Buffer C [20 mM Hepes buffer pH 7,150 mM NaCl] (1:400). The sample was
        then concentrated (Amicon Ultra-15 Centrifugal Filter; Merck) and
        purified by gel filtration in buffer C over a HiLoad 16/600 Superdex 200
        pg column.
      </p>
      <h2 id="secreted-igg-g6-g6des13-and-fab-d441des-production-in-suspension">
        Secreted IgG (G6, G6<sup>des13</sup>) and Fab (D44.1<sup>des</sup>)
        production in suspension
      </h2>
      <p>
        Antibodies were expressed in suspension-HEK293F cells, grown in
        FreeStyle medium (Gibco), in a shaking incubator (115 rpm), at 37°C, in
        a controlled environment of 8% CO<sub>2</sub>. The variable regions of
        the different heavy and light chains were cloned separately, upstream of
        IgG1 human Ab scaffolds, into p3BNC plasmids. Transfections were done
        using linear 40 kDa polyethyleneimine (PEI) (Polysciences) at 3 mg of
        PEI per 1 mg of plasmid DNA per 1 L of culture, at a cell density of 1
        million cells/ml. Growth media were collected after 5–7 days and
        separated from cells by centrifugation at 600 x g. Media were then
        supplemented with 0.02% (wt/vol) sodium azide and 0.1 mM PMSF and
        further clarified by centrifugation at 16,840 x g for 30 min.
      </p>
      <h2 id="fab-production-d441-g6-g6des1-g6des13">
        Fab production (D44.1, G6, G6<sup>des1</sup>, G6<sup>des13</sup>)
      </h2>
      <p>
        Adherent HEK293T cells were cotransfected with genes encoding the light
        and heavy chain Fabs (heavy chain fused to C-terminal His tag) in p3BNC
        plasmids using linear PEI as a transfection reagent (12.5 μg/12.5 μg/50
        μg, respectively, per 15-cm plate). Seventy-two hours post-transfection,
        the medium containing the secreted protein was collected (~250 ml).
      </p>
      <h2 id="fab-purification-d441-d441des-g6-g6des1-g6des13">
        Fab purification (D44.1, D44.1<sup>des</sup>, G6, G6<sup>des1</sup>,
        G6<sup>des13</sup>)
      </h2>
      <p>
        The filtered medium was concentrated to ~200 ml using a diafiltration
        device (QuixStand Benchtop System; GE Healthcare). The medium
        composition was exchanged to buffer A [50 mM Tris pH 8 and 150 mM NaCl]
        using the same device. This was loaded on a HisTrap HP 5 ml column (GE
        Healthcare). Washed with 15 bed volumes of 20 mM Tris pH 8, 150 mM NaCl
        and 10mM imidazole and was eluted with 20 mM Tris pH 8, 150 mM NaCl and
        250 mM imidazole. Imidazole was removed from the eluate by dialysis
        against Buffer A (1:400). The sample was then concentrated (Amicon
        Ultra-15 Centrifugal Filter; Merck) and purified by gel filtration in
        buffer A over a HiLoad 16/600 Superdex 200 pg column.
      </p>
      <h2 id="apparent-tm-and-aggregation-onset-measurements">
        Apparent <em>T</em><sub><em>m</em></sub> and aggregation onset
        measurements
      </h2>
      <p>
        The apparent melting temperature of the antibodies was determined by
        Prometheus NT. Plex instrument (NanoTemper Technologies), a label-free
        method. Fabs obtained from secreted Fab production in adherent cells
        (D44.1, G6, G6<sup>des1</sup>, G6<sup>des13</sup>) and from production
        in suspension (D44.1<sup>des</sup>) were diluted to 0.2 mg/ml (in 20 mM
        Hepes pH 7 and 50mM NaCl for anti-lysozyme antibodies and in 20 mM Hepes
        pH 7.5, 150 mM NaCl for anti VEGF antibodies). The temperature was
        ramped from 25°C to 100°C at 0.05°C/s, and both <em>T</em
        ><sub><em>m</em></sub> and aggregation-onset temperature were measured.
      </p>
      <h2 id="surface-plasmon-resonance">Surface-plasmon resonance</h2>
      <p>
        Surface plasmon resonance experiments on the anti-lysozyme (D44.1 and
        D44.1<sup>des</sup> expressed in bacteria) and anti-VEGF antibodies (G6,
        G6<sup>des1</sup> and G6<sup>des13</sup> expressed in adherent cells)
        were carried out on a Biacore T200 instrument (GE Healthcare) at 25°C
        with HBS-N EP+ [10 mM Hepes, 150 mM NaCl, 3 mM EDTA, 0.005% vol/vol
        surfactant P20 (pH 7.4)]. For binding analysis, 1,000–1,600 response
        units (RU) of Fab were captured on a CM5 sensor chip. Samples of
        different protein concentrations were injected over the surface at a
        flow rate of 30 μL/min for 240 s, and the chip was washed with buffer
        for 2,000 s. If necessary, surface regeneration was performed with 30 s
        injection of 50 mM NaOH (D44.1<sup>des</sup>) or 10 mM NaOH (VEGF
        antibodies) at a flow rate of 30 μL/min. One flow cell contained no
        ligand and was used as a reference. The acquired data were analyzed
        using the device’s software, and kinetic fits were performed.
      </p>
      <h2 id="igg-western-blot-analysis-g6-g6des1-g6des13">
        IgG Western blot analysis (G6, G6<sup>des1</sup>, G6<sup>des13</sup>)
      </h2>
      <p>
        HEK293T cells were seeded on a 24-well plate pre-coated with
        poly-L-lysine at 120,000 cells/well. The next day, cells were
        transfected with 1 μg DNA mixture consisting of 200 ng pLXN plasmid
        encoding Luciferase, 400 ng of a plasmid encoding the light chains and
        400 ng of a plasmid encoding the heavy chains of the designated
        antibodies. Each transfection was carried in 100 μl DMEM in which 2 μg
        of linear 40,000 Da PEI (Polysciences) per μg of DNA were mixed. The
        transfection mixture was added to cells, for a total volume of 400 μl
        DMEM per well. 4 hours after transfection, cells were washed and fresh 1
        ml DMEM with 1% penicillin and streptomycin, glutamine and non-essential
        amino acids was applied. 72 hours post-transfection supernatant was
        separated from cells and the cells were resuspended in 500 μl PBS. A
        sample of 100 μl from the suspended cells from each well was transferred
        to 96-well white plates (Nunc) with 100 μl of Bright-Glo reagent
        (Promega) to quantify the level of luciferase as a proxy for the
        transfection efficiency. Adjusted volumes of supernatants based on the
        luciferase levels were loaded on a gradient gel (Bio-Rad) and run
        according to manufacturer&#39;s instructions. Semi-dry blotting was
        performed to a nitrocellulose membrane followed by blocking in 5% milk
        powder in TBST (0.1% Tween 20, 20 mM Tris pH 8.0, 150 mM sodium
        chloride) buffer for 30 min at room temperature. Donkey anti-human IgG
        conjugated to HRP (Abcam) was used to detect the human IgG scaffold for
        1 h at room temperature.
      </p>
      <h2 id="mass-spectrometry-sample-preparation">
        Mass spectrometry sample preparation
      </h2>
      <p>
        Following IgG production in suspension (as described above), clarified
        media were aliquoted, snap frozen in liquid nitrogen and stored at
        -80°C. On the day of the measurements, samples were thawed and buffer
        exchanged into 1 M ammonium acetate, pH 7, using Micro Bio-Spin 6
        Columns (Bio-Rad). To break all disulfide bonds, antibodies were then
        reduced for 4 h at 37°C in the presence of 20 mM TCEP, followed by two
        consecutive buffer exchanges into 1 M and 150 mM ammonium acetate,
        respectively.
      </p>
      <h2 id="native-mass-spectrometry">Native-mass spectrometry</h2>
      <p>
        Nanoelectrospray ionization (nano-ESI) MS experiments were performed on
        a modified Q-Exactive Plus Orbitrap EMR (Thermo Fisher Scientific,
        Bremen, Germany) [<cite
          ><a href="#pcbi.1007207.ref070">#pcbi.1007207.ref070</a></cite
        >]. All spectra are shown without smoothing. The instrument was
        calibrated externally, using cesium iodide. Typically, an aliquot of 2
        μl protein solution was loaded into a gold-coated nano-ESI capillary
        prepared in-house, as previously described [<cite
          ><a href="#pcbi.1007207.ref071">#pcbi.1007207.ref071</a></cite
        >], and sprayed into the instrument. Conditions within the mass
        spectrometer were adjusted to preserve noncovalent interactions. The
        source was operated in positive mode, the capillary voltage was set to
        1.7 kV, the capillary temperature was 180°C and argon was used as the
        collision gas in the higher-energy collision-induced dissociation (HCD)
        cell. MS spectra were recorded at a resolution of 10,000 and HCD voltage
        was set to 50 V, at trapping gas pressure setting of 3.9, which
        corresponds to HV pressure of 1.04 x 10<sup>−4</sup> mbar and UHV
        pressure of 2.35 x 10<sup>−10</sup> mbar. Bent flatapole DC bias and
        axial gradient were set to 2 V and 25 V, respectively.
      </p>
      <h2 id="gas-phase-stability-assay">Gas-phase stability assay</h2>
      <p>
        Antibody stability was monitored by tandem MS (MS/MS), at different HCD
        voltages. The 23<sup>+</sup> charge state of the G6 and G6<sup
          >des13</sup
        >
        antibodies was isolated in the quadrupole, with an isolation window of
        20 m/z, and the transmitted ions were subjected to collision-induced
        dissociation in the HCD cell, at a gradient of accelerating voltages
        ranging between 50–200 V. The relative abundance of the full IgG’s and
        the dissociated light chains, recorded at the different HCD voltages,
        was determined by measuring their peak heights. The total intensity of
        the light chains was calculated as the sum of intensities of their
        corresponding charge states. In each experimental condition, the total
        intensities of all the measured species were summed and referenced as
        100% intensity. The relative intensity of each species was then
        calculated as a percentage of the total intensity. The stability assay
        was performed six times. Error bars represent standard deviation.
      </p>
      <h2 id="anti-qsox1-antibody-production">
        Anti-QSOX1 antibody production
      </h2>
      <p>
        The coding sequences for variable domains of antibody 492.1 were fused
        to human antibody constant regions [<cite
          ><a href="#pcbi.1007207.ref072">#pcbi.1007207.ref072</a></cite
        >]. Mutations were introduced by site-directed mutagenesis into the
        resulting hybrid antibody expression plasmids according to published
        procedures [<cite
          ><a href="#pcbi.1007207.ref073">#pcbi.1007207.ref073</a></cite
        >]. Plasmids were transfected into suspension-adapted suspension-HEK
        293F cells. The day before transfection, cells were split to 0.7 x
        10<sup>6</sup> cells/ml. For parallel expression of the parent hybrid
        antibody and the 20 variants, transfections were performed using 0.5 μg
        of each plasmid (heavy and light Ab chains) mixed with 3 μg PEI Max
        reagent (Polysciences Inc.) and incubated 20 min in 24-well tissue
        culture trays prior to addition of 1 ml cells per well. Plates were then
        agitated vigorously in a tissue culture incubator/shaker to prevent cell
        settling. After 4 days, cultures were transferred to microfuge tubes,
        and cells were pelleted by centrifugation at 500 x g for 10 min.
        Supernatants were transferred to fresh microfuge tubes, from which
        aliquots were taken for quantification of antibody expression and
        activity. For purification of selected Ab designs, transfections were
        done in 40 ml volumes, and plasmid and PEI Max amounts were scaled up
        accordingly. Cultures were grown for 6 days, and Ab was purified from
        the supernatant by protein G affinity chromatography (GE Healthcare).
      </p>
      <h2 id="qsox1-dot-blot-and-western-blot-assays">
        QSOX1 dot blot and Western blot assays
      </h2>
      <p>
        Relative antibody concentrations were determined from culture
        supernatants by dot and Western blotting. Blotting was conducted in
        triplicate for each of two biological replicates. For dot blots, 2 μl of
        each supernatant was spotted onto nitrocellulose membranes. Membranes
        were then covered with a blocking solution of PBS containing 0.1% Tween
        (PBS-T) and 5% bovine serum albumin (BSA) and gently agitated for 1 h at
        room temperature. For western blots, 10 μl of each supernatant was
        applied with non-reducing gel loading buffer to 10% SDS polyacrylamide
        gels. After electrophoresis, proteins were transferred to
        nitrocellulose, and the membranes were incubated in PBS-T with 5% BSA
        under gentle agitation. For both dot and Western blots, horseradish
        peroxidase-conjugated antibody recognizing human Fc was added to the
        blocking solution after the first hour, and incubation/shaking was
        continued for another 45 min. The membrane was then washed three times
        for 5 min each with PBS-T, and the blot was developed using SuperSignal
        West Pico (ThermoFisher) chemiluminescent substrate. Dot and band
        intensities were recorded on a ChemiDoc XRS+ system (Bio-Rad).
      </p>
      <h2 id="qsox1-inhibition-assays">QSOX1 inhibition assays</h2>
      <p>
        QSOX1 inhibition assays were conducted by using
        5,5-dithio-bis-2-nitrobenzoic acid (DTNB) to quantify the remaining
        dithiothreitol (DTT) after incubation with purified recombinant QSOX1
        and HEK293 culture supernatants or purified antibody. Culture
        supernatants (25 μl) were mixed in a clear, flat-bottom, 96-well plate
        with 12.5 μl of 40 nM QSOX1, and reactions were initiated by injection
        of 12.5 μl 600 μM DTT (final concentrations 10 nM QSOX1 and 150 μM DTT).
        Reactions were stopped after 30 min by adding 150 μl 500 μM DTNB, and
        absorbance at 412 nm was measured after 5 min in a Tecan microplate
        reader.
      </p>
      <p>
        Purified antibody variants were quantified by absorbance at 280 nm after
        dilution into 6 M guanidine dissolved in PBS, using an extinction
        coefficient of 187,000 M<sup>-1</sup>cm<sup>-1</sup>. Purified
        antibodies (12.5 μl) at concentrations of 40 nM, 100 nM, and 200 nM were
        mixed in a 96-well plate with 12.5 μl 100 nM QSOX1, and reactions were
        initiated by injection of 25 μl 600 μM DTT (final concentrations 25 nM
        QSOX1, 300 μM DTT, and 10, 25, or 50 nM antibody). Reactions were
        stopped after 20 min by adding 150 μl 500 μM DTNB, and absorbance at 412
        nm was measured after 5 min. Background-subtracted absorbance readings
        were normalized relative to the uninhibited and fully inhibited
        reactions (the latter mimicked by leaving QSOX1 out of the reaction),
        and results were plotted in <a href="#pcbi.1007207.g005">Fig 5C</a> as
        the relative inhibitory activity.
      </p>
      <h1 id="supporting-information">Supporting information</h1>
      S1 Fig
      <h1 id=""></h1>
      <p>
        <strong
          >a. Mutational tolerance mapping of the anti-lysozyme antibody
          D44.1.</strong
        >
        Mutations that were enriched, depleted, or had insufficient data in deep
        sequencing are marked in blue, red, and gray respectively. Wild type
        amino acids are indicated in one-letter codes for each position.
        Disulfide-bonded cysteines are marked in black triangles, and
        light-heavy chain interface positions in which point mutations exhibited
        over threefold enrichment relative to wild type, are marked in pink
        triangles.
        <strong>b.</strong> Qualitative binding titrations using yeast display
        for D44.1, D44.1<sup>des</sup>, and seven point mutants that comprise
        D44.1des using yeast surface display. Binding fluorescence intensities
        are relative to the highest concentration of 1 μM lysozyme.
      </p>
      <p>(TIF)</p>
      S2 Fig
      <h1 id="-1"></h1>
      <p>
        <strong>a.</strong> The crystal structure of D44.1<sup>des</sup> (yellow
        and green for heavy and light chains, respectively) shows high accuracy
        relative to the computational design (lavender). Electron density at 2
        σ. <strong>b.</strong> Crystallographic analysis of D44.1<sup>des</sup>
        shows high agreement with D44.1 (0.7 Å Cα root-mean-square deviation),
        including in the orientations of binding-surface residues (sticks; D44.1
        in gray).
      </p>
      <p>(TIF)</p>
      S3 Fig
      <h1
        id="computational-mutation-tolerance-mapping-enriches-for-low-energy-designs"
      >
        Computational mutation tolerance mapping enriches for low-energy
        designs.
      </h1>
      <p>
        (blue) the distribution of Rosetta energies relative to G6 of a
        selection of &gt;150,000 unique multipoint mutants at 11 positions
        encoded in the tolerated sequence space computed by PSSM (≥-1) and ΔΔ<em
          >G</em
        >
        (≤+1 R.e.u.) filters. (green) a random set of multipoint mutants at 30
        vL-vH interface (all interface positions were allowed), where any of the
        19 amino acid mutations was allowed at each mutated position. In both
        sets, the same number of multipoint mutants was analyzed, and the same
        distribution of the number of mutations relative to G6 was implemented.
        37% of the multipoint mutants had energies that were more favorable than
        G6, whereas less than 0.03% of the random mutants had more favorable
        energies than G6. Thus computational mutation tolerance mapping enriches
        for improved mutants by over 1,100-fold relative to random multipoint
        mutations.
      </p>
      <p>(TIF)</p>
      S4 Fig
      <h1 id="g6-g6des1-and-g6des13-fab-expression-and-purification">
        G6, G6<sup>des1</sup>, and G6<sup>des13</sup> Fab expression and
        purification.
      </h1>
      <p>
        (a) Following Ni-NTA purification, G6 exhibits the expected band at 50
        kDa, and additional bands at approximately 100 kDa, indicative of sample
        heterogeneity. G6<sup>des13</sup> and G6<sup>des1</sup>, by contrast,
        primarily elute at the 50 kDa size range with no detectable higher-mass
        bands. (b) Designs G6<sup>des13</sup> and G6<sup>des1</sup> after gel
        filtration run at their expected sizes. The status of reducing
        conditions (without DTT and boiling) is indicated at the bottom of the
        gels.
      </p>
      <p>(TIF)</p>
      S5 Fig
      <h1
        id="secreted-full-length-igg1-g6-and-g6des13-antibodies-were-reduced-and-analyzed-by-native-mass-spec-directly-from-the-growth-medium"
      >
        Secreted full-length IgG1 G6 and G6<sup>des13</sup> antibodies were
        reduced and analyzed by native mass-spec directly from the growth
        medium.
      </h1>
      <p>
        Upper panels show the full spectra. Charge state series of the two
        antibodies are labeled by dark blue and light blue circles,
        respectively. The +23 charge state of each antibody was isolated in the
        quadrupole and subjected to a gradual elevation of collision voltage in
        a stepwise manner, ranging from 50 to 200 V. Light chains, which
        gradually dissociated from the intact antibodies, are labeled the by red
        and orange circles.
      </p>
      <p>(TIF)</p>
      S6 Fig
      <h1
        id="all-20-h4921-designs-were-expressed-and-their-activities-from-culture-supernatants-were-measured-as-described-in-the-methods"
      >
        All 20 h492.1 designs were expressed, and their activities from culture
        supernatants were measured as described in the methods.
      </h1>
      <p>
        The highest values in the blot reflect the greatest amounts of substrate
        remaining at the end of a QSOX1 sulfhydryl oxidase activity assay,
        indicating the greatest inhibition of QSOX1 by the antibody. Due to
        differences in expression levels (<a href="#pcbi.1007207.g005"
          >Fig 5A and 5B</a
        >), inhibitory activity in this experiment reflects a combination of
        expression yield and intrinsic activity. The designs with results
        plotted in color (yellow and pink) were expressed in larger volumes,
        purified, and compared quantitatively for inhibitory activity compared
        to the parental 492.1 antibody purified from a hybridoma (<a
          href="#pcbi.1007207.g005"
          >Fig 5C</a
        >).
      </p>
      <p>(TIF)</p>
      S1 Table
      <h1
        id="data-collection-and-refinement-statistics-for-d441des-pdb-code-6gc2"
      >
        Data collection and refinement statistics for D44.1des, PDB code 6GC2.
      </h1>
      <p>(XLSX)</p>
      S2 Table
      <h1
        id="the-mutated-positions-and-identities-in-g6-designs-colored-according-to-their-physicochemical-properties-and-sorted-by-normalized-fluorescence-value-measured-by-yeast-display-experiments"
      >
        The mutated positions and identities in G6 designs, colored according to
        their physicochemical properties and sorted by normalized fluorescence
        value (measured by yeast display experiments).
      </h1>
      <p>(DOCX)</p>
      S3 Table
      <h1
        id="the-mutated-positions-and-identities-in-anti-qsox1-4921-designs-colored-according-to-their-physicochemical-properties"
      >
        The mutated positions and identities in anti-QSOX1 492.1 designs,
        colored according to their physicochemical properties.
      </h1>
      <p>(DOCX)</p>
      S4 Table
      <h1
        id="log-enrichment-of-the-deep-mutational-scanning-data-of-anti-lysozyme-antibody-d44"
      >
        Log-enrichment of the deep mutational scanning data of anti-lysozyme
        antibody D44.
      </h1>
      <p>
        Data retrieved from the deep mutational scanning analysis of enrichment
        over WT for single point substitutions.
      </p>
      <p>(XLSX)</p>
      S1 Protocol
      <h1
        id="rosettascript-for-refinement-of-structures-retrieved-from-the-pdb"
      >
        RosettaScript for refinement of structures retrieved from the PDB.
      </h1>
      <p>(TXT)</p>
      S2 Protocol
      <h1 id="rosettascript-for-single-point-mutational-scanning">
        RosettaScript for single-point mutational scanning.
      </h1>
      <p>(TXT)</p>
      S3 Protocol
      <h1 id="rosettascript-for-combinatorial-sequence-design">
        RosettaScript for combinatorial sequence design.
      </h1>
      <p>
        An example of a protocol for designing a specific combinatorial mutant.
      </p>
      <p>(TXT)</p>
      S1 Text
      <h1 id="dna-sequences-of-tested-constructs">
        DNA sequences of tested constructs.
      </h1>
      <p>(DOCX)</p>
      S2 Text
      <h1 id="amino-acid-sequences-of-g6-and-g6des13-iggs">
        Amino acid sequences of G6 and G6des13 IgGs.
      </h1>
      <p>Protein sequences used in the mass spectrometry analyses.</p>
      <p>(DOCX)</p>
      <section>
        <h2>References</h2>
        <ol class="references">
          <li
            id="pcbi.1007207.ref001"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Affinity Maturation Increases the Stability and Plasticity of the
              Fv Domain of Anti-protein Antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JP Acierno"
                    ><span itemprop="givenName">JP</span
                    ><span itemprop="familyName">Acierno</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BC Braden"
                    ><span itemprop="givenName">BC</span
                    ><span itemprop="familyName">Braden</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Klinke"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Klinke</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="FA Goldbaum"
                    ><span itemprop="givenName">FA</span
                    ><span itemprop="familyName">Goldbaum</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Cauerhff"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Cauerhff</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2007">2007</time>
          </li>
          <li
            id="pcbi.1007207.ref002"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Developability assessment in pharmaceutical industry: An
              integrated group approach for selecting developable
              candidates</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Saxena"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Saxena</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Panicucci"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Panicucci</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Joshi"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Joshi</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Garad"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Garad</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2009">2009</time>
          </li>
          <li
            id="pcbi.1007207.ref003"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Isolating and engineering human antibodies using yeast surface
              display</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Chao"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Chao</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="WL Lau"
                    ><span itemprop="givenName">WL</span
                    ><span itemprop="familyName">Lau</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BJ Hackel"
                    ><span itemprop="givenName">BJ</span
                    ><span itemprop="familyName">Hackel</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SL Sazinsky"
                    ><span itemprop="givenName">SL</span
                    ><span itemprop="familyName">Sazinsky</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SM Lippow"
                    ><span itemprop="givenName">SM</span
                    ><span itemprop="familyName">Lippow</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KD Wittrup"
                    ><span itemprop="givenName">KD</span
                    ><span itemprop="familyName">Wittrup</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref004"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Directed evolution of antibody fragments with monovalent
              femtomolar antigen-binding affinity</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="ET Boder"
                    ><span itemprop="givenName">ET</span
                    ><span itemprop="familyName">Boder</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KS Midelfort"
                    ><span itemprop="givenName">KS</span
                    ><span itemprop="familyName">Midelfort</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KD Wittrup"
                    ><span itemprop="givenName">KD</span
                    ><span itemprop="familyName">Wittrup</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2000">2000</time>
          </li>
          <li
            id="pcbi.1007207.ref005"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Substantial energetic improvement with minimal structural
              perturbation in a high affinity mutant antibody</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KS Midelfort"
                    ><span itemprop="givenName">KS</span
                    ><span itemprop="familyName">Midelfort</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="HH Hernandez"
                    ><span itemprop="givenName">HH</span
                    ><span itemprop="familyName">Hernandez</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SM Lippow"
                    ><span itemprop="givenName">SM</span
                    ><span itemprop="familyName">Lippow</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Tidor"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Tidor</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CL Drennan"
                    ><span itemprop="givenName">CL</span
                    ><span itemprop="familyName">Drennan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KD Wittrup"
                    ><span itemprop="givenName">KD</span
                    ><span itemprop="familyName">Wittrup</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2004">2004</time>
          </li>
          <li
            id="pcbi.1007207.ref006"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Efficient affinity maturation of antibody variable domains
              requires co-selection of compensatory mutations to maintain
              thermodynamic stability</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MC Julian"
                    ><span itemprop="givenName">MC</span
                    ><span itemprop="familyName">Julian</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Li"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Li</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Garde"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Garde</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Wilen"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Wilen</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="PM Tessier"
                    ><span itemprop="givenName">PM</span
                    ><span itemprop="familyName">Tessier</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref007"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >High affinity, developability and functional size: The holy grail
              of combinatorial antibody library generation</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Ponsel"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Ponsel</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Neugebauer"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Neugebauer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Ladetzki-Baehs"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Ladetzki-Baehs</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Tissot"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Tissot</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2011">2011</time>
          </li>
          <li
            id="pcbi.1007207.ref008"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Protein aggregation and bioprocessing</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MEM Cromwell"
                    ><span itemprop="givenName">MEM</span
                    ><span itemprop="familyName">Cromwell</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="E Hilario"
                    ><span itemprop="givenName">E</span
                    ><span itemprop="familyName">Hilario</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="F Jacobson"
                    ><span itemprop="givenName">F</span
                    ><span itemprop="familyName">Jacobson</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref009"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Effects of protein aggregates: an immunologic perspective</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="AS Rosenberg"
                    ><span itemprop="givenName">AS</span
                    ><span itemprop="familyName">Rosenberg</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref010"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Developability studies before initiation of process development:
              improving manufacturability of monoclonal antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="X Yang"
                    ><span itemprop="givenName">X</span
                    ><span itemprop="familyName">Yang</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="W Xu"
                    ><span itemprop="givenName">W</span
                    ><span itemprop="familyName">Xu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Dukleska"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Dukleska</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Benchaar"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Benchaar</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Mengisen"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Mengisen</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Antochshuk"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Antochshuk</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2013">2013</time>
          </li>
          <li
            id="pcbi.1007207.ref011"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Strategies and challenges for the next generation of therapeutic
              antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Beck"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Beck</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Wurch"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Wurch</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Bailly"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Bailly</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="N Corvaia"
                    ><span itemprop="givenName">N</span
                    ><span itemprop="familyName">Corvaia</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2010">2010</time>
          </li>
          <li
            id="pcbi.1007207.ref012"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Computational design of antibody-affinity improvement beyond in
              vivo maturation</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SM Lippow"
                    ><span itemprop="givenName">SM</span
                    ><span itemprop="familyName">Lippow</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KD Wittrup"
                    ><span itemprop="givenName">KD</span
                    ><span itemprop="familyName">Wittrup</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Tidor"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Tidor</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2007">2007</time>
          </li>
          <li
            id="pcbi.1007207.ref013"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Design of therapeutic proteins with enhanced stability</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="N Chennamsetty"
                    ><span itemprop="givenName">N</span
                    ><span itemprop="familyName">Chennamsetty</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Voynov"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Voynov</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Kayser"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Kayser</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Helk"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Helk</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BL Trout"
                    ><span itemprop="givenName">BL</span
                    ><span itemprop="familyName">Trout</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2009">2009</time>
          </li>
          <li
            id="pcbi.1007207.ref014"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Biophysical properties of the clinical-stage antibody
              landscape</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Jain"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Jain</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Sun"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Sun</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Durand"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Durand</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Hall"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Hall</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="NR Houston"
                    ><span itemprop="givenName">NR</span
                    ><span itemprop="familyName">Houston</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JH Nett"
                    ><span itemprop="givenName">JH</span
                    ><span itemprop="familyName">Nett</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref015"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Boosting antibody developability through rational sequence
              optimization</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Seeliger"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Seeliger</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Schulz"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Schulz</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Litzenburger"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Litzenburger</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Spitz"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Spitz</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Hoerer"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Hoerer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Blech"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Blech</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2015">2015</time>
          </li>
          <li
            id="pcbi.1007207.ref016"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >General strategy for the generation of human antibody variable
              domains with increased aggregation resistance</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Dudgeon"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Dudgeon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Rouet"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Rouet</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Kokmeijer"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Kokmeijer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Schofield"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Schofield</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Stolp"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Stolp</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Langley"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Langley</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref017"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Structure-based design of supercharged, highly thermoresistant
              antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="AE Miklos"
                    ><span itemprop="givenName">AE</span
                    ><span itemprop="familyName">Miklos</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Kluwe"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Kluwe</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BS Der"
                    ><span itemprop="givenName">BS</span
                    ><span itemprop="familyName">Der</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Pai"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Pai</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Sircar"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Sircar</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R a. Hughes"
                    ><span itemprop="givenName">R a.</span
                    ><span itemprop="familyName">Hughes</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref018"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Aggregation-resistant domain antibodies selected on phage by heat
              denaturation</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Jespers"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Jespers</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Schon"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Schon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Famm"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Famm</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Winter"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Winter</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2004">2004</time>
          </li>
          <li
            id="pcbi.1007207.ref019"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Structural mechanism for affinity maturation of an anti-lysozyme
              antibody</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Cauerhff"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Cauerhff</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="FA Goldbaum"
                    ><span itemprop="givenName">FA</span
                    ><span itemprop="familyName">Goldbaum</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BC Braden"
                    ><span itemprop="givenName">BC</span
                    ><span itemprop="familyName">Braden</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2004">2004</time>
          </li>
          <li
            id="pcbi.1007207.ref020"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Automated Structure-and Sequence-Based Design of Proteins for
              High Bacterial Expression and Stability</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Goldenzweig"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Goldenzweig</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Goldsmith"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Goldsmith</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SE Hill"
                    ><span itemprop="givenName">SE</span
                    ><span itemprop="familyName">Hill</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Gertman"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Gertman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Laurino"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Laurino</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Ashani"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Ashani</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref021"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Principles of Protein Stability and Their Application in
              Computational Design</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Goldenzweig"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Goldenzweig</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2018">2018</time>
          </li>
          <li
            id="pcbi.1007207.ref022"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >One-step design of a stable variant of the malaria invasion
              protein RH5 for use as a vaccine immunogen</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Campeotto"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Campeotto</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Goldenzweig"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Goldenzweig</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Davey"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Davey</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Barfod"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Barfod</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JM Marshall"
                    ><span itemprop="givenName">JM</span
                    ><span itemprop="familyName">Marshall</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SE Silk"
                    ><span itemprop="givenName">SE</span
                    ><span itemprop="familyName">Silk</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref023"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Automated selection of stabilizing mutations in designed and
              natural proteins</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Borgo"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Borgo</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JJ Havranek"
                    ><span itemprop="givenName">JJ</span
                    ><span itemprop="familyName">Havranek</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref024"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Optimization of affinity, specificity and function of designed
              influenza inhibitors using deep sequencing</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="TA Whitehead"
                    ><span itemprop="givenName">TA</span
                    ><span itemprop="familyName">Whitehead</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Chevalier"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Chevalier</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Song"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Song</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Dreyfus"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Dreyfus</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C De Mattos"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">De Mattos</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref025"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Deep mutational scanning: a new style of protein science</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="DM Fowler"
                    ><span itemprop="givenName">DM</span
                    ><span itemprop="familyName">Fowler</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Fields"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Fields</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2014">2014</time>
          </li>
          <li
            id="pcbi.1007207.ref026"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >High-resolution mapping of protein sequence-function
              relationships</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="DM Fowler"
                    ><span itemprop="givenName">DM</span
                    ><span itemprop="familyName">Fowler</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CL Araya"
                    ><span itemprop="givenName">CL</span
                    ><span itemprop="familyName">Araya</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="EH Kellogg"
                    ><span itemprop="givenName">EH</span
                    ><span itemprop="familyName">Kellogg</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JJ Stephany"
                    ><span itemprop="givenName">JJ</span
                    ><span itemprop="familyName">Stephany</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Baker"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Baker</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2010">2010</time>
          </li>
          <li
            id="pcbi.1007207.ref027"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Mutational landscape of antibody variable domains reveals a
              switch modulating the interdomain conformational dynamics and
              antigen binding</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Koenig"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Koenig</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CV Lee"
                    ><span itemprop="givenName">CV</span
                    ><span itemprop="familyName">Lee</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BT Walters"
                    ><span itemprop="givenName">BT</span
                    ><span itemprop="familyName">Walters</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Janakiraman"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Janakiraman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Stinson"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Stinson</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="TW Patapoff"
                    ><span itemprop="givenName">TW</span
                    ><span itemprop="familyName">Patapoff</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref028"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Deep mutational scanning of an antibody against epidermal growth
              factor receptor using mammalian cell display and massively
              parallel pyrosequencing</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CM Forsyth"
                    ><span itemprop="givenName">CM</span
                    ><span itemprop="familyName">Forsyth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="V Juan"
                    ><span itemprop="givenName">V</span
                    ><span itemprop="familyName">Juan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Akamatsu"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Akamatsu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RB DuBridge"
                    ><span itemprop="givenName">RB</span
                    ><span itemprop="familyName">DuBridge</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Doan"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Doan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="AV Ivanov"
                    ><span itemprop="givenName">AV</span
                    ><span itemprop="familyName">Ivanov</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2013">2013</time>
          </li>
          <li
            id="pcbi.1007207.ref029"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Robust in vitro affinity maturation strategy based on
              interface-focused high-throughput mutational scanning</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Fujino"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Fujino</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Fujita"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Fujita</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Wada"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Wada</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Fujishige"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Fujishige</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Kanamori"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Kanamori</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Hunt"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Hunt</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref030"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Measuring the sequence-affinity landscape of antibodies with
              massively parallel titration curves</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RM Adams"
                    ><span itemprop="givenName">RM</span
                    ><span itemprop="familyName">Adams</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Mora"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Mora</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="AM Walczak"
                    ><span itemprop="givenName">AM</span
                    ><span itemprop="familyName">Walczak</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JB Kinney"
                    ><span itemprop="givenName">JB</span
                    ><span itemprop="familyName">Kinney</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref031"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Saturation scanning of ubiquitin variants reveals a common hot
              spot for binding to USP2 and USP21</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Leung"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Leung</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Dekel"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Dekel</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JM Shifman"
                    ><span itemprop="givenName">JM</span
                    ><span itemprop="familyName">Shifman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SS Sidhu"
                    ><span itemprop="givenName">SS</span
                    ><span itemprop="familyName">Sidhu</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref032"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Computational design of novel protein binders and experimental
              affinity maturation</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="TA Whitehead"
                    ><span itemprop="givenName">TA</span
                    ><span itemprop="familyName">Whitehead</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Baker"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Baker</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2013">2013</time>
          </li>
          <li
            id="pcbi.1007207.ref033"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Three-dimensional structures of the free and the
              antigen-complexed Fab from monoclonal anti-lysozyme antibody
              D44.1</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BC Braden"
                    ><span itemprop="givenName">BC</span
                    ><span itemprop="familyName">Braden</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Souchon"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Souchon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JL Eiselé"
                    ><span itemprop="givenName">JL</span
                    ><span itemprop="familyName">Eiselé</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="GA Bentley"
                    ><span itemprop="givenName">GA</span
                    ><span itemprop="familyName">Bentley</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="TN Bhat"
                    ><span itemprop="givenName">TN</span
                    ><span itemprop="familyName">Bhat</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Navaza"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Navaza</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1994">1994</time>
          </li>
          <li
            id="pcbi.1007207.ref034"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Structure of antibody-antigen complexes: implications for immune
              recognition</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="PM Colman"
                    ><span itemprop="givenName">PM</span
                    ><span itemprop="familyName">Colman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1988">1988</time>
          </li>
          <li
            id="pcbi.1007207.ref035"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Antibody evolution constrains conformational heterogeneity by
              tailoring protein dynamics</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Zimmermann"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Zimmermann</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="EL Oakman"
                    ><span itemprop="givenName">EL</span
                    ><span itemprop="familyName">Oakman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="IF Thorpe"
                    ><span itemprop="givenName">IF</span
                    ><span itemprop="familyName">Thorpe</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="X Shi"
                    ><span itemprop="givenName">X</span
                    ><span itemprop="familyName">Shi</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Abbyad"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Abbyad</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CL Brooks"
                    ><span itemprop="givenName">CL</span
                    ><span itemprop="familyName">Brooks</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref036"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Trends in antibody sequence changes during the somatic
              hypermutation process</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="LA Clark"
                    ><span itemprop="givenName">LA</span
                    ><span itemprop="familyName">Clark</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Ganesan"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Ganesan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Papp"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Papp</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="HWT van Vlijmen"
                    ><span itemprop="givenName">HWT</span
                    ><span itemprop="familyName">van Vlijmen</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref037"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline">Humanised antibodies</span>
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JR Adair"
                    ><span itemprop="givenName">JR</span
                    ><span itemprop="familyName">Adair</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="DS Athwal"
                    ><span itemprop="givenName">DS</span
                    ><span itemprop="familyName">Athwal</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JS Emtage"
                    ><span itemprop="givenName">JS</span
                    ><span itemprop="familyName">Emtage</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1995">1995</time>
          </li>
          <li
            id="pcbi.1007207.ref038"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >AbDesign: An algorithm for combinatorial backbone design guided
              by natural conformations and sequences</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="GD Lapidoth"
                    ><span itemprop="givenName">GD</span
                    ><span itemprop="familyName">Lapidoth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Baran"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Baran</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="GM Pszolla"
                    ><span itemprop="givenName">GM</span
                    ><span itemprop="familyName">Pszolla</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Norn"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Norn</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Alon"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Alon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MD Tyka"
                    ><span itemprop="givenName">MD</span
                    ><span itemprop="familyName">Tyka</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2015">2015</time>
          </li>
          <li
            id="pcbi.1007207.ref039"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Principles for computational design of binding antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Baran"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Baran</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MG Pszolla"
                    ><span itemprop="givenName">MG</span
                    ><span itemprop="familyName">Pszolla</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="GD Lapidoth"
                    ><span itemprop="givenName">GD</span
                    ><span itemprop="familyName">Lapidoth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Norn"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Norn</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Dym"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Dym</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Unger"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Unger</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref040"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Highly active enzymes by automated combinatorial backbone
              assembly and sequence design</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Lapidoth"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Lapidoth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Khersonsky"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Khersonsky</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Lipsh"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Lipsh</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Dym"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Dym</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Albeck"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Albeck</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Rogotner"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Rogotner</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2018">2018</time>
          </li>
          <li
            id="pcbi.1007207.ref041"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Automated Design of Efficient and Functionally Diverse Enzyme
              Repertoires</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Khersonsky"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Khersonsky</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Lipsh"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Lipsh</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Z Avizemer"
                    ><span itemprop="givenName">Z</span
                    ><span itemprop="familyName">Avizemer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Ashani"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Ashani</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Goldsmith"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Goldsmith</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Leader"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Leader</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2018">2018</time>
          </li>
          <li
            id="pcbi.1007207.ref042"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Ultrahigh specificity in a network of computationally designed
              protein-interaction pairs</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Netzer"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Netzer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Listov"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Listov</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Lipsh"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Lipsh</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Dym"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Dym</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Albeck"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Albeck</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Knop"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Knop</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2018">2018</time>
          </li>
          <li
            id="pcbi.1007207.ref043"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Why reinvent the wheel? Building new proteins based on ready-made
              parts</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Khersonsky"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Khersonsky</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref044"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Analysis and prediction of VH/VL packing in antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="KR Abhinandan"
                    ><span itemprop="givenName">KR</span
                    ><span itemprop="familyName">Abhinandan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="ACR Martin"
                    ><span itemprop="givenName">ACR</span
                    ><span itemprop="familyName">Martin</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2010">2010</time>
          </li>
          <li
            id="pcbi.1007207.ref045"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Structure-Function Studies of Two Synthetic Anti-vascular
              Endothelial Growth Factor Fabs and Comparison with the Avastin
              Fab</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Fuh"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Fuh</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Wu"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Wu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="W-C Liang"
                    ><span itemprop="givenName">W-C</span
                    ><span itemprop="familyName">Liang</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Ultsch"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Ultsch</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CV Lee"
                    ><span itemprop="givenName">CV</span
                    ><span itemprop="familyName">Lee</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Moffat"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Moffat</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2006">2006</time>
          </li>
          <li
            id="pcbi.1007207.ref046"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Loss of Nkx3.1 leads to the activation of discrete downstream
              target genes during prostate tumorigenesis</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Song"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Song</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Zhang"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Zhang</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MA Watson"
                    ><span itemprop="givenName">MA</span
                    ><span itemprop="familyName">Watson</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="PA Humphrey"
                    ><span itemprop="givenName">PA</span
                    ><span itemprop="familyName">Humphrey</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Lim"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Lim</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Milbrandt"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Milbrandt</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2009">2009</time>
          </li>
          <li
            id="pcbi.1007207.ref047"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >An inhibitory antibody blocks the first step in the
              dithiol/disulfide relay mechanism of the enzyme QSOX1</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Grossman"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Grossman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Alon"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Alon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Ilani"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Ilani</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Fass"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Fass</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2013">2013</time>
          </li>
          <li
            id="pcbi.1007207.ref048"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >The dynamic disulphide relay of quiescin sulphydryl oxidase</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Alon"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Alon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Grossman"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Grossman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Gat"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Gat</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="VK Kodali"
                    ><span itemprop="givenName">VK</span
                    ><span itemprop="familyName">Kodali</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="F DiMaio"
                    ><span itemprop="givenName">F</span
                    ><span itemprop="familyName">DiMaio</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Mehlman"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Mehlman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2012">2012</time>
          </li>
          <li
            id="pcbi.1007207.ref049"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >High-affinity human antibodies from phage-displayed synthetic Fab
              libraries with a single framework scaffold</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CV Lee"
                    ><span itemprop="givenName">CV</span
                    ><span itemprop="familyName">Lee</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="W-C Liang"
                    ><span itemprop="givenName">W-C</span
                    ><span itemprop="familyName">Liang</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MS Dennis"
                    ><span itemprop="givenName">MS</span
                    ><span itemprop="familyName">Dennis</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Eigenbrot"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Eigenbrot</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SS Sidhu"
                    ><span itemprop="givenName">SS</span
                    ><span itemprop="familyName">Sidhu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Fuh"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Fuh</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2004">2004</time>
          </li>
          <li
            id="pcbi.1007207.ref050"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Role of conformational sampling in computing mutation-induced
              changes in protein structure and stability</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="EH Kellogg"
                    ><span itemprop="givenName">EH</span
                    ><span itemprop="familyName">Kellogg</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Leaver-Fay"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Leaver-Fay</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Baker"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Baker</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2011">2011</time>
          </li>
          <li
            id="pcbi.1007207.ref051"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Eris: an automated estimator of protein stability</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Yin"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Yin</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="F Ding"
                    ><span itemprop="givenName">F</span
                    ><span itemprop="familyName">Ding</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="NV Dokholyan"
                    ><span itemprop="givenName">NV</span
                    ><span itemprop="familyName">Dokholyan</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2007">2007</time>
          </li>
          <li
            id="pcbi.1007207.ref052"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Developability assessment during the selection of novel
              therapeutic antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Jarasch"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Jarasch</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Koll"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Koll</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JT Regula"
                    ><span itemprop="givenName">JT</span
                    ><span itemprop="familyName">Regula</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Bader"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Bader</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Papadimitriou"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Papadimitriou</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Kettenberger"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Kettenberger</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2015">2015</time>
          </li>
          <li
            id="pcbi.1007207.ref053"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >De novo design of protein homo-oligomers with modular
              hydrogen-bond network-mediated specificity</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SE Boyken"
                    ><span itemprop="givenName">SE</span
                    ><span itemprop="familyName">Boyken</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Z Chen"
                    ><span itemprop="givenName">Z</span
                    ><span itemprop="familyName">Chen</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="B Groves"
                    ><span itemprop="givenName">B</span
                    ><span itemprop="familyName">Groves</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RA Langan"
                    ><span itemprop="givenName">RA</span
                    ><span itemprop="familyName">Langan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Oberdorfer"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Oberdorfer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Ford"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Ford</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref054"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Inspired by nature: designed proteins have structural features
              resembling those of natural active sites</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Netzer"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Netzer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref055"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"></span>
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Ben-Nissan"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Ben-Nissan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Vimer"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Vimer</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Warszawski"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Warszawski</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Katz"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Katz</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Yona"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Yona</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Unger"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Unger</span></span
                  >
                </li>
              </ol>
            </div>
          </li>
          <li
            id="pcbi.1007207.ref056"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Disulfide bond generation in mammalian blood serum: detection and
              purification of quiescin-sulfhydryl oxidase</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="BA Israel"
                    ><span itemprop="givenName">BA</span
                    ><span itemprop="familyName">Israel</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Jiang"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Jiang</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SA Gannon"
                    ><span itemprop="givenName">SA</span
                    ><span itemprop="familyName">Gannon</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="C Thorpe"
                    ><span itemprop="givenName">C</span
                    ><span itemprop="familyName">Thorpe</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2014">2014</time>
          </li>
          <li
            id="pcbi.1007207.ref057"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >The association of heavy and light chain variable domains in
              antibodies: implications for antigen specificity</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Chailyan"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Chailyan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Marcatili"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Marcatili</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Tramontano"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Tramontano</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2011">2011</time>
          </li>
          <li
            id="pcbi.1007207.ref058"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Second antibody modeling assessment (AMA-II)</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JC Almagro"
                    ><span itemprop="givenName">JC</span
                    ><span itemprop="familyName">Almagro</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Teplyakov"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Teplyakov</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Luo"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Luo</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RW Sweet"
                    ><span itemprop="givenName">RW</span
                    ><span itemprop="familyName">Sweet</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Kodangattil"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Kodangattil</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="F Hernandez-Guzman"
                    ><span itemprop="givenName">F</span
                    ><span itemprop="familyName">Hernandez-Guzman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2014">2014</time>
          </li>
          <li
            id="pcbi.1007207.ref059"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >High-accuracy modeling of antibody structures by a search for
              minimum-energy recombination of backbone fragments</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="CH Norn"
                    ><span itemprop="givenName">CH</span
                    ><span itemprop="familyName">Norn</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Lapidoth"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Lapidoth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref060"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >AbPredict 2: a server for accurate and unstrained structure
              prediction of antibody variable domains</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Lapidoth"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Lapidoth</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Parker"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Parker</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Prilusky"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Prilusky</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2019">2019</time>
          </li>
          <li
            id="pcbi.1007207.ref061"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Structural evidence for induced fit as a mechanism for
              antibody-antigen recognition</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JM Rini"
                    ><span itemprop="givenName">JM</span
                    ><span itemprop="familyName">Rini</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="U Schulze-Gahmen"
                    ><span itemprop="givenName">U</span
                    ><span itemprop="familyName">Schulze-Gahmen</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="IA Wilson"
                    ><span itemprop="givenName">IA</span
                    ><span itemprop="familyName">Wilson</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1992">1992</time>
          </li>
          <li
            id="pcbi.1007207.ref062"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >A theory of the structure and process of formation of
              antibodies</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="L Pauling"
                    ><span itemprop="givenName">L</span
                    ><span itemprop="familyName">Pauling</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1940">1940</time>
          </li>
          <li
            id="pcbi.1007207.ref063"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Major antigen-induced domain rearrangements in an antibody</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RL Stanfield"
                    ><span itemprop="givenName">RL</span
                    ><span itemprop="familyName">Stanfield</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Takimoto-Kamimura"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Takimoto-Kamimura</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JM Rini"
                    ><span itemprop="givenName">JM</span
                    ><span itemprop="familyName">Rini</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="AT Profy"
                    ><span itemprop="givenName">AT</span
                    ><span itemprop="familyName">Profy</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="IA Wilson"
                    ><span itemprop="givenName">IA</span
                    ><span itemprop="familyName">Wilson</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="1993">1993</time>
          </li>
          <li
            id="pcbi.1007207.ref064"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Mutational scanning reveals the determinants of protein insertion
              and association energetics in the plasma membrane</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Elazar"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Elazar</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="J Weinstein"
                    ><span itemprop="givenName">J</span
                    ><span itemprop="familyName">Weinstein</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Biran"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Biran</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Fridman"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Fridman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="E Bibi"
                    ><span itemprop="givenName">E</span
                    ><span itemprop="familyName">Bibi</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref065"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >An efficient one-step site-directed deletion, insertion, single
              and multiple-site plasmid mutagenesis protocol</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Liu"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Liu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JH Naismith"
                    ><span itemprop="givenName">JH</span
                    ><span itemprop="familyName">Naismith</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2008">2008</time>
          </li>
          <li
            id="pcbi.1007207.ref066"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Frozen competent yeast cells that can be transformed with high
              efficiency using the LiAc/SS carrier DNA/PEG method</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RD Gietz"
                    ><span itemprop="givenName">RD</span
                    ><span itemprop="familyName">Gietz</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="RH Schiestl"
                    ><span itemprop="givenName">RH</span
                    ><span itemprop="familyName">Schiestl</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2007">2007</time>
          </li>
          <li
            id="pcbi.1007207.ref067"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >RosettaScripts: a scripting language interface to the Rosetta
              macromolecular modeling suite</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SJ Fleishman"
                    ><span itemprop="givenName">SJ</span
                    ><span itemprop="familyName">Fleishman</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Leaver-Fay"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Leaver-Fay</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="JE Corn"
                    ><span itemprop="givenName">JE</span
                    ><span itemprop="familyName">Corn</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="E-M Strauch"
                    ><span itemprop="givenName">E-M</span
                    ><span itemprop="familyName">Strauch</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="SD Khare"
                    ><span itemprop="givenName">SD</span
                    ><span itemprop="familyName">Khare</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="N Koga"
                    ><span itemprop="givenName">N</span
                    ><span itemprop="familyName">Koga</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2011">2011</time>
          </li>
          <li
            id="pcbi.1007207.ref068"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Combined covalent-electrostatic model of hydrogen bonding
              improves structure prediction with Rosetta</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MJ O’Meara"
                    ><span itemprop="givenName">MJ</span
                    ><span itemprop="familyName">O’Meara</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Leaver-Fay"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Leaver-Fay</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MD Tyka"
                    ><span itemprop="givenName">MD</span
                    ><span itemprop="familyName">Tyka</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Stein"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Stein</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="K Houlihan"
                    ><span itemprop="givenName">K</span
                    ><span itemprop="familyName">Houlihan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="F DiMaio"
                    ><span itemprop="givenName">F</span
                    ><span itemprop="familyName">DiMaio</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2015">2015</time>
          </li>
          <li
            id="pcbi.1007207.ref069"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Simultaneous Optimization of Biomolecular Energy Functions on
              Features from Small Molecules and Macromolecules</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Park"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Park</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Bradley"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Bradley</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="P Greisen"
                    ><span itemprop="givenName">P</span
                    ><span itemprop="familyName">Greisen</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Liu"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Liu</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="VK Mulligan"
                    ><span itemprop="givenName">VK</span
                    ><span itemprop="familyName">Mulligan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="DE Kim"
                    ><span itemprop="givenName">DE</span
                    ><span itemprop="familyName">Kim</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2016">2016</time>
          </li>
          <li
            id="pcbi.1007207.ref070"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Triple-Stage Mass Spectrometry Unravels the Heterogeneity of an
              Endogenous Protein Complex</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Ben-Nissan"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Ben-Nissan</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="ME Belov"
                    ><span itemprop="givenName">ME</span
                    ><span itemprop="familyName">Belov</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="D Morgenstern"
                    ><span itemprop="givenName">D</span
                    ><span itemprop="familyName">Morgenstern</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Levin"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Levin</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="O Dym"
                    ><span itemprop="givenName">O</span
                    ><span itemprop="familyName">Dym</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="G Arkind"
                    ><span itemprop="givenName">G</span
                    ><span itemprop="familyName">Arkind</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2017">2017</time>
          </li>
          <li
            id="pcbi.1007207.ref071"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Analyzing large protein complexes by structural mass
              spectrometry</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="N Kirshenbaum"
                    ><span itemprop="givenName">N</span
                    ><span itemprop="familyName">Kirshenbaum</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="I Michaelevski"
                    ><span itemprop="givenName">I</span
                    ><span itemprop="familyName">Michaelevski</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Sharon"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Sharon</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2010">2010</time>
          </li>
          <li
            id="pcbi.1007207.ref072"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Efficient generation of monoclonal antibodies from single human B
              cells by single cell RT-PCR and expression vector cloning</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Tiller"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Tiller</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="E Meffre"
                    ><span itemprop="givenName">E</span
                    ><span itemprop="familyName">Meffre</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="S Yurasov"
                    ><span itemprop="givenName">S</span
                    ><span itemprop="familyName">Yurasov</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="M Tsuiji"
                    ><span itemprop="givenName">M</span
                    ><span itemprop="familyName">Tsuiji</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="MC Nussenzweig"
                    ><span itemprop="givenName">MC</span
                    ><span itemprop="familyName">Nussenzweig</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="H Wardemann"
                    ><span itemprop="givenName">H</span
                    ><span itemprop="familyName">Wardemann</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2008">2008</time>
          </li>
          <li
            id="pcbi.1007207.ref073"
            itemtype="https://schema.org/CreativeWork"
            itemscope="true"
            itemprop="citation"
          >
            <span itemprop="headline"
              >Applications of the Restriction Free (RF) cloning procedure for
              molecular manipulations and protein expression</span
            >
            <div>
              <ol class="authors">
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="T Unger"
                    ><span itemprop="givenName">T</span
                    ><span itemprop="familyName">Unger</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Jacobovitch"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Jacobovitch</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="A Dantes"
                    ><span itemprop="givenName">A</span
                    ><span itemprop="familyName">Dantes</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="R Bernheim"
                    ><span itemprop="givenName">R</span
                    ><span itemprop="familyName">Bernheim</span></span
                  >
                </li>
                <li
                  itemtype="https://schema.org/Person"
                  itemscope="true"
                  itemprop="author"
                >
                  <span itemprop="name" content="Y Peleg"
                    ><span itemprop="givenName">Y</span
                    ><span itemprop="familyName">Peleg</span></span
                  >
                </li>
              </ol>
            </div>
            <time itemprop="datePublished" datetime="2010">2010</time>
          </li>
        </ol>
      </section>
    </article>
  </body>
</html>
